All dysplastic lesions of the cervix uteri, vagina or vulva

N14_FEMALE_GENITAL_DYSPLASIA_ALL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N87\|N89[0-3]\|N90[0-3]\|D06\|D071\|D072 Hospital discharge: ICD-9 — 6221A\|6221B\|6221C\|0781C\|2331A\|2333A\|6230B\|6230C\|2333B Cause of death: ICD-10 — N87\|N89[0-3]\|N90[0-3]\|D06\|D071\|D072 Cause of death: ICD-9 — 6221A\|6221B\|6221C\|0781C\|2331A\|2333A\|6230B\|6230C\|2333B 2 out of 7 registries used, show all original rules.	13774
4. Check minimum number of events None	13774
5. Include endpoints None	13774
6. Filter based on genotype QC (FinnGen only)	13774

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_FEMALE_GENITAL_DYSPLASIA_ALL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N87\|N89[0-3]\|N90[0-3]\|D06\|D071\|D072
HD_ICD_9	6221A\|6221B\|6221C\|0781C\|2331A\|2333A\|6230B\|6230C\|2333B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N87\|N89[0-3]\|N90[0-3]\|D06\|D071\|D072
COD_ICD_9	6221A\|6221B\|6221C\|0781C\|2331A\|2333A\|6230B\|6230C\|2333B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to All dysplastic lesions of the cervix uteri, vagina or vulva based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	86287	86287	-
Only index persons	84042	84042	-
Unadjusted period prevalence (%)
Whole population	2.47	2.47	-
Only index persons	3.09	3.09	-
Median age at first event (years)
Whole population	-	35.10	-
Only index persons	-	34.95	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13774	13774	-
Unadjusted period prevalence (%)	4.70	4.70	-
Median age at first event (years)	35.69	35.69	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12198: Matched controls
121626

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

16.2

323.0

600

386

C539, 6666, 0

ICD-O-3

125.2

323.0

1139

100

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

113.0

323.0

416

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

8.6

323.0

970

1211

8326

FHL

Batch conization

96.2

323.0

365

ZXC00

NOMESCO Finland

Use of diathermy

46.9

323.0

502

111

N90.0

ICD-10 Finland

Mild vulvar dysplasia

+∞

323.0

380

N89.0

ICD-10 Finland

Mild vaginal dysplasia

+∞

323.0

449

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

131.6

323.0

6110

922

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

254.6

323.0

2319

112

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

7545.0

323.0

3796

N87.0

ICD-10 Finland

Mild cervical dysplasia

1231.6

323.0

4115

N87.1

ICD-10 Finland

Moderate cervical dysplasia

12253.2

323.0

3562

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

36.1

323.0

8572

7478

A63.0

ICD-10 Finland

Anogenital (venereal) warts

7.1

323.0

1708

2717

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

13.9

323.0

7060

10960

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

29.8

323.0

6463

4439

LEB00

NOMESCO Finland

Biopsy of vagina

14.8

323.0

960

699

ULA02

NOMESCO Finland

Kolposcopy

46.3

323.0

9049

7111

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

+∞

323.0

587

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

+∞

323.0

381

LDA10

NOMESCO Finland

Curettage of cervix uteri

20.7

323.0

3548

2358

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

+∞

277.8

266

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.0

275.3

5936

39320

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

8.5

263.8

607

749

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

29.1

260.4

358

126

8070/2-C53.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of cervix uteri

39.3

257.8

330

N89.1

ICD-10 Finland

Moderate vaginal dysplasia

1276.5

257.7

251

D06.1

ICD-10 Finland

Carcinoma in situ: Exocervix

+∞

253.7

243

N90.1

ICD-10 Finland

Moderate vulvar dysplasia

+∞

246.4

236

6221C

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]

+∞

217.1

208

G01AA10

ATC

clindamycin; vaginal

2.0

212.8

3281

18542

N89.2

ICD-10 Finland

Severe vaginal dysplasia, not elsewhere classified

+∞

190.9

183

6221B

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]

+∞

183.6

176

6221A

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI LEVIS]

+∞

179.4

172

8325

FHL

Coagulation, cryo or laser in anesthesia or operating room

56.3

167.5

200

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

309.5

149.8

152

8474

FHL

Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia

29.7

148.1

202

8077/2-C51.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vulva, NOS

1337.1

135.5

132

8077/2-C53.1

ICD-O-3

Squamous intraepithelial neoplasia, high grade of exocervix

220.0

126.9

131

D06.9

ICD-10 Finland

Carcinoma in situ: Cervix, unspecified

+∞

124.0

119

8077/2-C52.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vagina, NOS

+∞

120.9

116

D06BB04

ATC

podophyllotoxin; topical

2.4

112.0

1075

4776

D07.1

ICD-10 Finland

Carcinoma in situ: Vulva

1065.0

108.5

106

R87.7

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal histological findings

11.6

107.4

205

179

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

103.7

2124

12792

X86

ICPC

Abnormal cervix smear

5.1

103.4

340

674

2331A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Cervix uteri

+∞

99.0

8411

FHL

Local change laser, coagulation, biopsy or removal

33.1

96.7

128

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

5.7

96.0

289

517

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

7.0

91.8

236

343

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

88.9

3829

28016

D06BB10

ATC

imiquimod; topical

2.7

87.6

653

2518

LFC00

NOMESCO Finland

Partial excision of vulva

20.1

84.2

128

P01AB01

ATC

metronidazole; oral, rectal

1.5

82.6

5203

41098

LDC00

NOMESCO Finland

Conisation of cervix uteri using knife

52.4

78.2

R87.2

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of other drugs, medicaments and biological substances

20.9

73.3

110

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

72.7

2000

12983

Z3231

NOMESCO Finland

Registered nurse

1.5

67.1

2704

19237

R87.1

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of hormones

25.9

66.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

64.5

733

3495

R87.0

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of enzymes

22.3

62.1

Z2221

NOMESCO Finland

Medical doctor

1.4

61.7

3405

25774

Z3232

NOMESCO Finland

Midwife

1.6

58.3

1867

12531

N87

ICD-10 Finland

Dysplasia of cervix uteri

32.8

54.7

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.5

50.3

1695

11476

A63.8

ICD-10 Finland

Other specified predominantly sexually transmitted diseases

12.3

49.7

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

13.6

49.7

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

9.6

48.5

101

106

R2110

NOMESCO Finland

Giving the first information

1.7

47.8

1040

6267

TLC02

NOMESCO Finland

Simple extraction of IUD

1.8

47.6

838

4721

J02AC01

ATC

fluconazole; systemic

1.3

47.6

6133

52739

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

45.7

2815

21512

SPAT1193

SPAT

Pap smear

1.5

43.5

1880

13409

N76.0

ICD-10 Finland

Acute vaginitis

1.6

43.2

1092

6857

G01AF01

ATC

metronidazole; vaginal

1.6

43.0

1369

9113

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

42.0

1878

13474

LDB10

NOMESCO Finland

Cryotherapy of cervix uteri

7.0

41.8

105

150

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

41.5

3253

25802

N90.3

ICD-10 Finland

Dysplasia of vulva, unspecified

407.8

41.1

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

2.5

39.8

324

1311

WX110

NOMESCO Finland

Local anesthesy

1.3

39.4

8148

73842

X23

ICPC

Fear sexually transm dis female

1.7

39.2

893

5441

N07BA03

ATC

varenicline; oral

1.9

36.9

583

3159

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

10.8

35.1

N89.3

ICD-10 Finland

Dysplasia of vagina, unspecified

120.0

33.6

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

32.8

1231

8481

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

32.4

987

6483

8140/2-C53.0

ICD-O-3

Adenocarcinoma in situ, NOS, of endocervix

+∞

32.3

N02AX02

ATC

tramadol; systemic, rectal

1.3

31.9

3642

30238

M03BX02

ATC

tizanidine; oral

1.3

31.9

7376

66734

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

10.0

31.9

LDB00

NOMESCO Finland

Excision of lesion of cervix uteri

2.7

31.3

220

819

X92

ICPC

Chlamydia infection genital female

2.6

31.3

228

868

N93.0

ICD-10 Finland

Postcoital and contact bleeding

3.3

31.3

162

494

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

10.2

29.2

O34.4

ICD-10 Finland

Maternal care for other abnormalities of cervix

7.2

29.0

J01DB01

ATC

cefalexin; oral

1.3

28.8

9473

88781

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

28.0

839

5481

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

27.9

907

6039

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

27.8

4172

35671

1390

FHL

Colposcopy

9.8

27.7

8140/2-C53.1

ICD-O-3

Adenocarcinoma in situ, NOS, of exocervix

100.0

27.6

8111

FHL

Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)

9.7

27.5

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

5.6

27.3

142

LCH11

NOMESCO Finland

Pharmacologic abortion

1.6

26.8

752

4832

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

3.2

26.6

140

433

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

26.1

2419

19425

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

26.1

620

3817

M54.5

ICD-10 Finland

Low back pain

1.3

26.0

3586

30289

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

26.0

4736

41293

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

25.5

977

6743

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

25.5

637

3973

8076/3-C53.9

ICD-O-3

Squamous cell carcinoma, microinvasive of cervix uteri

35.5

25.1

N02BE01

ATC

paracetamol; systemic, rectal

1.3

24.9

9662

91204

J01CA08

ATC

pivmecillinam; oral

1.2

24.9

5817

51991

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

24.5

10938

105101

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

24.3

8503

79146

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

24.2

1483

11182

SPAT1308

SPAT

Sexual health counselling

1.3

23.5

2115

16882

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.7

23.2

458

2674

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

2.0

23.0

284

1406

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

2.2

22.5

240

1116

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.9

22.5

331

1751

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

22.5

3733

32081

J01AA02

ATC

doxycycline; systemic

1.2

22.0

8571

80139

8070/2-C51.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of vulva, NOS

+∞

21.9

8071/2-C51.9

ICD-O-3

Differentiated intraepithelial neoplasia of vulva, NOS

114.9

21.5

X15

ICPC

Vaginal symptom/complaint other

1.6

21.2

523

3249

XLA10

NOMESCO Finland

1.5

21.2

674

4463

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

21.0

5552

49876

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

15.5

20.9

7950A

ICD-9 Finland

Nonspecific abnormal histological and immunological findings, Nonspecific abnormal Papanicolaou smear of cervix

10.0

20.7

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

20.5

3287

28068

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

20.4

4114

35974

N05CF01

ATC

zopiclone; oral

1.2

20.4

2658

22185

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

18.2

20.3

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

20.2

5992

54329

SPAT1283

SPAT

Restricted health certificate

1.2

20.1

2696

22567

J05AB01

ATC

aciclovir; systemic

1.3

20.0

2274

18665

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

12.0

19.9

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

19.8

6182

56282

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

19.6

4110

36033

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

19.6

4334

38190

K02.1

ICD-10 Finland

Caries of dentine

1.2

19.4

6667

61157

W11

ICPC

Contraception oral

1.3

19.1

1340

10295

C51.01

ICD-10 Finland

Squamous cell carcinoma of the labium majus

13.9

19.0

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

18.6

271

1431

N06AX11

ATC

mirtazapine; oral

1.2

18.2

3132

26886

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

18.1

980

7215

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

1.6

18.1

455

2847

J01DA01

ATC

[U] cefalexin; systemic

1.2

17.9

6993

64642

WX290

NOMESCO Finland

Other blockade of nerve

1.2

17.9

5427

49082

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

17.9

7797

72771

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

17.9

5793

52691

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

17.5

6715

61929

Z72.0

ICD-10 Finland

Tobacco use

2.0

17.4

230

1170

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

17.2

2459

20672

R74

ICPC

Upper respiratory infection acute

1.2

17.2

3789

33270

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

1.8

17.0

304

1721

J05AB11

ATC

valaciclovir; oral

1.3

17.0

1292

10039

N90.4

ICD-10 Finland

Leukoplakia of vulva

4.5

17.0

134

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

16.8

3641

31900

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

16.7

459

2936

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

16.7

406

2519

D07.2

ICD-10 Finland

Carcinoma in situ: Vagina

+∞

16.6

ZXC10

NOMESCO Finland

Use of laser

2.1

16.6

183

869

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.5

16.5

645

4466

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.6

16.5

381

2333

ULC02

NOMESCO Finland

Hysteroscopy

1.5

16.4

648

4498

8113

FHL

Fractional scraping

1.6

16.4

395

2442

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

16.4

8113

76223

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

1.7

16.2

345

2064

L04AX01

ATC

azathioprine; systemic

1.6

16.2

398

2478

J01EA01

ATC

trimethoprim; systemic

1.2

16.1

2857

24546

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

16.0

461

2987

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

15.9

4378

39128

J01MA02

ATC

ciprofloxacin; systemic

1.2

15.9

3169

27515

Z30.2

ICD-10 Finland

Sterilization

1.3

15.9

1413

11215

EBA00

NOMESCO Finland

Extraction of tooth

1.2

15.9

3065

26532

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

15.8

157

709

R87.3

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of substances chiefly nonmedicinal as to source

19.1

15.5

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

1.3

15.4

1006

7632

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

15.4

2333

19711

N30.0

ICD-10 Finland

Acute cystitis

1.3

15.4

1402

11160

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

7.6

15.3

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

15.2

2106

17620

WX002

NOMESCO Finland

Sedation and analgesia

1.3

15.2

1439

11513

A02BC02

ATC

pantoprazole; systemic

1.2

15.0

6343

58598

M79.6

ICD-10 Finland

Pain in limb

1.2

14.9

3495

30759

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.3

14.8

1464

11774

D82

ICPC

Teeth/gum disease

1.2

14.8

3934

35001

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

14.7

3962

35278

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.6

14.7

104

395

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.2

14.6

2283

19342

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.3

14.5

968

7373

8010/2-C53.9

ICD-O-3

Carcinoma in situ, NOS, of cervix uteri

149.7

14.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

14.2

2991

26060

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

14.1

2653

22871

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

14.0

267

1547

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

13.7

1541

12587

LCD10

NOMESCO Finland

Vaginal hysterectomy

1.6

13.7

368

2349

SPAT1312

SPAT

General health counselling

1.2

13.6

3221

28325

6230B

ICD-9 Finland

Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE MODERATA]

+∞

13.5

J01FF01

ATC

clindamycin; systemic

1.2

13.5

2459

21122

8339

FHL

Other measure in this category

5.2

13.5

N06AB04

ATC

citalopram; systemic

1.2

13.5

2166

18375

R05

ICPC

Cough

1.2

13.5

2151

18235

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

13.5

6480

60221

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

13.3

2606

22528

R87.8

ICD-10 Finland

Abnormal findings in specimens from female genital organs, other abnormal findings

3.1

13.2

223

N03AX16

ATC

pregabalin; oral

1.2

13.2

1966

16553

ZXE00

NOMESCO Finland

One hour or less

1.2

13.2

4160

37436

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.5

13.1

451

3049

M01AB05

ATC

diclofenac; systemic, rectal

1.2

13.1

7116

66665

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

13.0

4513

40895

N05BA04

ATC

oxazepam; oral

1.2

12.9

2443

21045

R51.80

ICD-10 Finland

Headache

1.2

12.9

1659

13749

LDA96

NOMESCO Finland

Other biopsy of cervix uteri

12.9

8327

FHL

Amputation portionis and conization

49.9

12.8

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

12.8

1687

14022

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

1.7

12.7

254

1497

2333B

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]

+∞

12.5

D07AD01

ATC

clobetasol; topical

1.3

12.5

1317

10670

7020X

ICD-9 Finland

Other dermatoses, Actinic keratosis[DERMATOSES PRAECANCEROSAE ALIAE]

129.8

12.4

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

12.4

3034

26723

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

12.2

1614

13407

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

12.2

980

7666

Z5132

NOMESCO Finland

Nursing associate professional

3.3

12.2

177

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

12.2

3295

29251

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

12.2

2065

17596

4044

NOMESCO Finland

7.4

12.1

L03

ICPC

Low back symptom/complaint

1.2

12.1

2351

20291

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

2.4

12.1

104

442

H02AB06

ATC

prednisolone; systemic

1.2

12.1

4387

39828

M01AH05

ATC

etoricoxib; oral

1.1

12.0

6169

57382

Z71.8

ICD-10 Finland

Other specified counselling

1.2

12.0

2550

22180

D19

ICPC

Teeth/gum symptom/complaint

1.2

12.0

2795

24506

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

11.9

1550

12860

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

11.8

4183

37876

Z2446

NOMESCO Finland

Social worker

1.4

11.8

524

3729

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

1.7

11.8

218

1257

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

2.0

11.7

143

713

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.6

11.7

274

1691

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.4

11.7

492

3468

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

11.6

1860

15753

LFD10

NOMESCO Finland

Vulvectomy and excision of regional lymph nodes

16.3

11.6

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.5

11.6

409

2782

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

1.7

11.6

239

1423

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

11.5

3069

27181

M01AE02

ATC

naproxen; oral, rectal

1.1

11.5

6304

58829

UJF32

NOMESCO Finland

Coloscopy

1.2

11.3

1798

15214

P01BA02

ATC

hydroxychloroquine; oral

1.3

11.2

757

5771

8112

FHL

Scraping the cervix

5.3

11.2

SPAT1263

SPAT

Sampling

1.1

11.1

4308

39215

N90.9

ICD-10 Finland

Noninflammatory disorder of vulva and perineum, unspecified

2.5

11.1

341

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

10.9

3501

31434

AA1AD

NOMESCO Finland

CT of head and brain

1.2

10.8

1379

11407

8070/3-C53.1

ICD-O-3

Squamous cell carcinoma, NOS, of exocervix

15.4

10.8

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.3

10.7

747

5725

Z01.2

ICD-10 Finland

Dental examination

1.1

10.7

4571

41856

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

2.6

10.7

277

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

10.6

879

6899

P01

ICPC

Feeling anxious/nervous/tense

1.2

10.6

1296

10667

WZA90

NOMESCO Finland

Other doctors statement

1.2

10.5

2171

18810

B02AA02

ATC

tranexamic acid; systemic

1.2

10.5

1944

16683

C53.12

ICD-10 Finland

Adenocarcinoma of the exocervix

9.1

10.5

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.3

10.4

853

6685

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

10.4

877

6902

D01

ICPC

Abdominal pain/cramps general

1.3

10.4

1038

8351

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

10.2

808

6302

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

10.2

927

7363

X91

ICPC

Condylomata acuminata female

3.1

10.2

169

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

4.6

10.2

LDC96

NOMESCO Finland

Other excision of cervix uteri

23.3

10.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

10.2

1142

9311

SPAT1192

SPAT

Gynaecological examination

1.2

10.2

1614

13646

A03

ICPC

Fever

1.2

10.2

1753

14937

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

10.1

1075

8712

SPAT1301

SPAT

No procedures

1.2

10.1

2687

23766

62191

ICD-8 Finland

Other diseases of cervix, Dysplasia portionis uteri

3.1

10.1

171

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

4.2

10.1

T74.1

ICD-10 Finland

Physical abuse

1.7

10.0

191

1113

LDC10

NOMESCO Finland

Partial excision of cervix uteri

8.4

10.0

W14

ICPC

Contraception female other

1.3

10.0

696

5337

N76.6

ICD-10 Finland

Ulceration of vulva

2.2

10.0

422

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

9.9

597

4477

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

1.6

9.9

255

1614

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

9.9

786

6141

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

9.9

1017

8212

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

9.8

217

1318

ZX120

NOMESCO Finland

Intravenous

1.3

9.8

672

5141

N06AX16

ATC

venlafaxine; oral

1.2

9.8

1537

12982

X85

ICPC

Cervical disease NOS

5.9

9.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

9.7

2018

17489

L04AA01

ATC

[U] ciclosporin; systemic

2.0

9.7

113

556

N06AB06

ATC

sertraline; oral

1.2

9.6

1152

9460

N88.2

ICD-10 Finland

Stricture and stenosis of cervix uteri

3.8

9.6

103

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

9.5

2716

24130

SPAT1254

SPAT

Administration of medicine

1.3

9.5

929

7449

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.2

9.5

1346

11250

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.2

9.5

1039

8450

R21

ICPC

Throat symptom/complaint

1.2

9.5

2483

21920

LEB10

NOMESCO Finland

Excision of lesion of vagina

2.5

9.4

273

G01AF04

ATC

miconazole; vaginal

1.3

9.4

601

4551

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

9.4

2497

22068

D06.7

ICD-10 Finland

Carcinoma in situ: Other parts of cervix

+∞

9.4

W12

ICPC

Contraception intrauterine

1.2

9.4

1584

13471

127

Kela drug reimbursment

Transplant complication

2.2

9.3

402

M25.5

ICD-10 Finland

Pain in joint

1.2

9.3

2927

26183

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

9.3

319

2161

J01FA10

ATC

azithromycin; systemic

1.1

9.3

6939

65603

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

9.3

5522

51493

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

9.5

9.2

N03AX12

ATC

gabapentin; oral

1.2

9.2

1235

10266

TAC99

NOMESCO Finland

Other blockade for chronic pain

2.7

9.2

217

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.2

9.2

1923

16666

R42

ICD-10 Finland

Dizziness and giddiness

1.2

9.1

1582

13478

Z3226

NOMESCO Finland

Physiotherapist

1.2

9.1

1462

12368

Z00.0

ICD-10 Finland

General medical examination

1.2

9.1

1476

12507

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

1.4

9.0

443

3220

L04AA06

ATC

mycophenolic acid; systemic

2.0

8.9

114

582

SDA05

NOMESCO Finland

Very demanding and lengthy parodonthologic therapy

1.4

8.8

416

2998

N06AB10

ATC

escitalopram; oral

1.2

8.8

2351

20771

A02BC05

ATC

esomeprazole; systemic

1.1

8.8

3708

33819

Z30.8

ICD-10 Finland

Other contraceptive management

1.5

8.8

308

2099

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

3.9

8.8

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.3

8.7

776

6156

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

8.7

2139

18773

R03AC02

ATC

salbutamol; inhalant

1.1

8.7

5780

54174

EMB10

NOMESCO Finland

Tonsillectomy

1.3

8.6

738

5822

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

8.6

1532

13087

N02AA05

ATC

oxycodone; systemic

1.3

8.6

696

5455

Z87.4

ICD-10 Finland

Personal history of diseases of the genitourinary system

1.9

8.5

119

628

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.2

8.5

1042

8580

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

8.5

257

1696

X14

ICPC

Vaginal discharge

1.5

8.5

297

2021

P17

ICPC

Tobacco abuse

1.9

8.5

123

659

N39.3

ICD-10 Finland

Stress incontinence

1.3

8.4

684

5361

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

8.4

1486

12684

KMAK

NOMESCO Finland

1.1

8.3

6294

59365

D11

ICPC

Diarrhoea

1.2

8.3

1198

10032

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.1

8.3

2706

24243

X29

ICPC

Genital sympt/compl female other

1.8

8.3

146

834

N07BB01

ATC

disulfiram; oral

1.5

8.2

248

1636

Z01.8

ICD-10 Finland

Other specified special examinations

1.2

8.2

1812

15764

SPAT1153

SPAT

Removal of sutures

1.2

8.2

2362

20974

K05.30

ICD-10 Finland

Periodontitis complex

1.3

8.1

817

6576

B03XA01

ATC

erythropoietin; parenteral

3.4

8.1

109

O34.3

ICD-10 Finland

Maternal care for cervical incompetence

2.2

8.1

368

N05AH04

ATC

quetiapine; oral

1.2

8.1

1604

13828

A11CC03

ATC

alfacalcidol; systemic

1.9

8.1

110

579

8542/3-C51.9

ICD-O-3

Paget disease, extramammary of vulva, NOS

33.3

8.1

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.2

8.0

1122

9364

LFD00

NOMESCO Finland

Vulvectomy

22.0

8.0

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

8.0

2273

20158

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

3.9

8.0

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

2.6

8.0

201

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

1.6

8.0

212

1359

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.3

7.9

623

4864

U01

ICPC

Dysuria/painful urination

1.3

7.9

705

5591

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.4

7.9

326

2295

J01CA04

ATC

amoxicillin; systemic

1.1

7.9

9504

91960

J20

ICD-10 Finland

Acute bronchitis

1.3

7.9

796

6412

C07AA05

ATC

propranolol; systemic

1.2

7.8

2055

18115

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.1

7.8

429

A02BC03

ATC

lansoprazole; oral

1.1

7.8

2338

20802

R06.0

ICD-10 Finland

Dyspnoea

1.2

7.8

1774

15461

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.2

7.8

1425

12193

S06.0

ICD-10 Finland

Concussion

1.3

7.8

775

6231

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.1

7.8

2799

25227

M79.1

ICD-10 Finland

Myalgia

1.2

7.8

1275

10809

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

1.9

7.8

105

551

G01AX03

ATC

policresulen; vaginal

1.9

7.7

101

525

8077/2-C53.0

ICD-O-3

Squamous intraepithelial neoplasia, high grade of endocervix

44.9

7.7

8070/3-C52.9

ICD-O-3

Squamous cell carcinoma, NOS, of vagina, NOS

15.0

7.7

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

7.7

514

3923

A12AA04

ATC

calcium carbonate; oral

2.2

7.7

325

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

7.7

1695

14742

R4110

NOMESCO Finland

Physiotherapy

1.2

7.7

2056

18149

KAY40

NOMESCO Finland

0.6

7.6

114

1879

N17

ICPC

Vertigo/dizziness

1.3

7.6

737

5914

M54

ICD-10 Finland

Dorsalgia

1.2

7.6

1060

8850

XQ900

NOMESCO Finland

Photography of physically assaulted person

11.8

7.5

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

7.5

676

5374

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

7.5

661

5236

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

7.5

269

1846

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

2.7

7.5

176

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

7.5

1739

15189

G03CA04

ATC

estriol; systemic, vaginal

1.4

7.4

332

2375

N05BA01

ATC

diazepam; systemic, rectal

1.2

7.4

969

8029

ZXA00

NOMESCO Finland

Right side

1.2

7.4

1795

15726

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

7.4

1910

16810

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

7.4

1133

9543

P01AB02

ATC

tinidazole; oral, rectal

1.5

7.4

251

1701

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.0

7.4

421

C53.00

ICD-10 Finland

Malignant tumor of endocervix without histology

6.4

7.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.2

7.4

990

8228

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.5

7.4

270

1861

8140/3-C53.0

ICD-O-3

Adenocarcinoma, NOS, of endocervix

7.6

7.4

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

1.5

7.3

231

1543

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

7.3

570

4447

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

2.4

7.3

231

6230C

ICD-9 Finland

Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE GRAVIS]

+∞

7.3

T810, N872

ICD-10 Finland

+∞

7.3

C53.10

ICD-10 Finland

Malignant tumor of the exocervix without histology

10.8

7.3

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.4

7.3

307

2172

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

2.6

7.3

182

S01.51

ICD-10 Finland

Open wound on lip

1.9

7.3

105

565

X16

ICPC

Vulval symptom/complaint

1.6

7.2

164

1011

F32

ICD-10 Finland

Depressive episode

1.3

7.2

561

4375

8070/3-C53.0

ICD-O-3

Squamous cell carcinoma, NOS, of endocervix

15.7

7.2

N86

ICD-10 Finland

Erosion and ectropion of cervix uteri

2.5

7.2

201

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.2

7.2

978

8146

8511

FHL

Cervical dilation and drainage with suction

1.4

7.2

374

2748

R87.4

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal immunological findings

7.3

7.2

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.3

7.1

677

5416

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

7.1

3867

35700

ZX095

NOMESCO Finland

Combined chemoradiotherapy

2.9

7.1

141

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

7.1

1411

12163

ZXE10

NOMESCO Finland

More than one and less than three hours

1.1

7.1

3136

28614

WF002

NOMESCO Finland

Radical radiotherapy

1.6

7.0

152

926

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.0

7.0

128

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

1.6

7.0

150

912

SFA00

NOMESCO Finland

Small filling

1.2

7.0

1153

9776

L02

ICPC

Back symptom/complaint

1.2

7.0

836

6865

K50.8

ICD-10 Finland

Other Crohn disease

1.7

7.0

131

768

TQW40

NOMESCO Finland

Remowal of suture of skin

1.3

7.0

479

3673

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

1.3

7.0

686

5511

D10

ICPC

Vomiting

1.3

7.0

671

5380

D06BB03

ATC

aciclovir; topical

1.3

6.9

446

3386

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.3

6.9

559

4385

09992

ICD-8 Finland

Other veneral disease, Condyloma acuminatum

3.1

6.9

113

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

5.1

6.9

A51.3

ICD-10 Finland

Secondary syphilis of skin and mucous membranes

5.8

6.9

D73

ICPC

Gastroenteritis presumed infection

1.4

6.8

313

2252

L04AA05

ATC

[U] tacrolimus; systemic

8.2

6.8

H02AB07

ATC

prednisone; oral

1.2

6.8

1101

9327

C51.9

ICD-10 Finland

Malignant neoplasm: Vulva, unspecified

6.1

6.7

F32.1

ICD-10 Finland

Moderate depressive episode

1.3

6.7

604

4803

SPAT1058

SPAT

PEF monitoring instruction

1.3

6.7

575

4546

8513

FHL

Softening of cervix with abortifacient or laminars and associated surgical emptying of the uterus

1.4

6.7

274

1934

S18

ICPC

Laceration/cut

1.1

6.6

3136

28706

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.1

6.6

1964

17459

C51.00

ICD-10 Finland

Malignant tumor of the labium majus without histology

12.2

6.6

C52.91

ICD-10 Finland

Squamous cell carcinoma of the vagina

12.2

6.6

K04.0

ICD-10 Finland

Pulpitis

1.2

6.5

1033

8732

ZXA10

NOMESCO Finland

Bilateral

1.2

6.5

1315

11349

NOMESCO Finland

4.8

6.5

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

1.4

6.5

345

2547

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.2

6.5

1567

13723

JAH01

NOMESCO Finland

Laparoscopy

1.3

6.4

496

3868

V03AE02

ATC

sevelamer; oral

3.3

6.4

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

14.3

6.4

N05CF02

ATC

zolpidem; oral

1.2

6.4

1671

14719

J36

ICD-10 Finland

Peritonsillar abscess

1.4

6.4

300

2170

R53

ICD-10 Finland

Malaise and fatigue

1.1

6.4

1817

16100

SPAT1240

SPAT

Therapeutic discussion

1.2

6.3

1229

10572

ZXC96

NOMESCO Finland

Robot assisted procedure

1.8

6.3

518

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.1

6.3

2415

21815

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

6.3

101

567

LFC96

NOMESCO Finland

Other partial excision of vulva or perineum

11.0

6.3

LDA00

NOMESCO Finland

Dilatation of cervix uteri

1.8

6.3

538

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

0.9

6.3

1325

15086

6230A

ICD-9 Finland

Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE LEVIS]

9.2

6.3

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.5

6.2

191

1268

U02

ICPC

Urinary frequency/urgency

1.2

6.2

1156

9905

8070/3-C51.1

ICD-O-3

Squamous cell carcinoma, NOS, of labium minus

18.0

6.2

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.4

6.2

320

2352

LWA00

NOMESCO Finland

Repair of wound dehiscence in gynaecological surgery

3.6

6.2

A05

ICPC

Feeling ill

1.3

6.2

496

3886

X84

ICPC

Vaginitis/vulvitis NOS

1.8

6.2

102

575

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

6.2

353

2636

128

Kela drug reimbursment

Cancers of female genital organs

1.7

6.2

120

713

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

6.1

325

2399

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.5

6.1

199

1343

F43.00

ICD-10 Finland

Acute stress reaction mild

1.4

6.1

287

2076

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.1

6.1

101

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

2.0

6.1

334

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

6.1

1393

12146

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

1.5

6.0

181

1199

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

1.6

6.0

148

936

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

4.3

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3025130) Human papilloma virus identified in Specimen

2405

2389

11.91

307.65

2.3

1.4

—

(40768804) Tissue Pathology biopsy report

7643

50097

2.16

307.65

2.7

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2988

6868

5.24

307.65

2.2

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7473

36058

3.32

307.65

2.3

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

901

539

17.70

307.65

2.4

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4027

26424

1.73

167.46

2.4

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3634

23461

1.73

158.65

2.3

1.9

—

(4035726)

1487

8273

1.88

102.46

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2545

17652

1.53

74.08

2.0

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2026

13500

1.58

70.21

1.8

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

130

240

5.42

66.14

1.6

2.2

ug/l

7.1

2.5

0.61

147

(3037467) Urinalysis macro (dipstick) panel - Urine

8853

80672

1.25

33.09

4.4

4.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

8567

77889

1.25

32.13

4.3

3.9

e6/l

1959.9

1827.2

0.05

833

(3018095) Leukocytes [#/volume] in Urine

4267

36475

1.24

26.86

3.6

3.2

e6/l

60.6

79.2

2.00

2808

23765

(3013707) Erythrocyte sedimentation rate by Westergren method

9277

85825

1.23

26.20

4.2

3.8

mm/h

10.0

10.1

0.37

8758

80826

(46235355) HIV 1 and 2 tests - Meaningful Use set

4279

36684

1.23

25.99

2.1

2.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8908

82149

1.22

25.61

7.3

6.7

u/l

72.0

73.1

2.24

8388

77679

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1851

14370

1.32

25.47

2.7

2.5

e6/l

4.6

5.0

0.58

963

7271

(42870588) Differential panel, method unspecified - Blood

4209

36105

1.23

25.24

6.2

5.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1965

15409

1.31

25.13

2.6

2.4

e6/l

1.1

1.2

0.83

1071

8254

(3021601) Nitrite [Presence] in Urine by Test strip

6508

58333

1.21

24.77

4.7

4.5

estimate

0.0

0.16

1275

11703

(3009261) Glucose [Presence] in Urine by Test strip

6556

58812

1.21

24.71

3.5

3.3

estimate

0.0

0.83

1254

11578

(3035350) Ketones [Presence] in Urine by Test strip

6461

58068

1.20

23.30

3.5

3.3

estimate

0.0

0.16

1234

11393

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1154

8448

1.39

23.16

1.6

1.5

—

(3006315) Basophils [#/volume] in Blood

6357

57109

1.20

22.85

6.2

5.6

e9/l

0.0

0.03

5649

50431

(3002256) Pathology report gross observation

1928

15259

1.30

22.84

1.2

—

(3001604) Monocytes [#/volume] in Blood

6335

56905

1.20

22.77

6.2

5.6

e9/l

0.5

0.22

5653

50372

(3011397) Hemoglobin [Presence] in Urine by Test strip

3119

26150

1.24

22.75

3.5

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

3122

26232

1.24

22.24

3.1

2.7

e6/l

0.3

0.16

2291

19173

(3002582) Erythrocytes [#/volume] in Urine

3386

28765

1.22

21.60

3.1

2.7

e6/l

35.2

69.1

2.71

2522

21413

(36304419) Bacteria [Presence] in Urine

3122

26306

1.23

21.54

3.0

2.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11222

106594

1.25

21.51

9.9

9.0

ml/min/173m2

90.5

90.3

0.32

9197

87177

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12268

117847

1.31

21.18

11.9

10.5

mg/l

18.8

18.7

0.23

9559

90671

(3013115) Eosinophils [#/volume] in Blood

6548

59239

1.19

21.01

6.4

5.8

e9/l

0.2

0.30

5959

53218

(3019550) Sodium [Moles/volume] in Serum or Plasma

11846

113340

1.27

20.64

11.5

10.3

mmol/l

139.5

139.6

2.37

11541

110463

(3023103) Potassium [Moles/volume] in Serum or Plasma

11877

113685

1.28

20.54

11.6

10.4

mmol/l

3.9

0.20

11546

110531

(3019198) Lymphocytes [#/volume] in Blood

6522

59063

1.18

20.46

6.2

5.5

e9/l

2.0

0.06

5947

53264

(3006504) Eosinophils/100 leukocytes in Blood

5931

53382

1.18

19.72

6.3

5.6

2.7

2.8

0.45

5554

50008

(3019069) Monocytes/100 leukocytes in Blood

5952

53655

1.18

19.26

6.5

5.9

7.9

0.17

5610

50702

(3013650) Neutrophils [#/volume] in Blood by Automated count

7155

65536

1.18

18.94

8.8

8.4

e9/l

4.0

3.9

0.31

6341

57959

(3022096) Basophils/100 leukocytes in Blood

5727

51521

1.18

18.84

6.4

5.7

0.7

0.53

5355

48276

(3044640) Blood type and Crossmatch panel - Blood

4097

35872

1.19

18.41

2.1

2.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4705

41765

1.18

17.89

5.2

4.8

mmol/l

1.2

0.76

4291

38139

(3017143) Hepatitis C virus Ab [Presence] in Serum

2179

17978

1.24

17.87

1.7

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

6073

55055

1.17

17.81

6.1

5.4

56.4

56.5

0.39

5715

51985

(40758558) Short blood count panel - Blood

3243

27886

1.20

17.63

6.6

6.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

6140

55774

1.17

17.40

6.3

5.6

29.7

0.00

5761

52491

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5823

52720

1.17

17.10

5.6

5.3

umol/l

9.3

9.6

2.38

5485

49724

(3033658) Prothrombin time (PT) actual/Normal

2990

25581

1.21

17.07

3.8

3.3

97.3

98.4

1.75

2904

24764

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5212

46822

1.17

16.80

6.0

5.4

mmol/l

1.2

1.76

4468

39615

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3067

26390

1.20

16.36

2.1

1.9

—

(3026008) Bacteria identified in Urine by Culture

3743

32932

1.18

15.25

2.7

2.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12694

123191

1.30

15.06

9.6

8.7

u/l

23.8

24.0

0.41

12350

119828

(3021589) Normoblasts [#/volume] in Blood

5546

50418

1.16

14.61

8.5

8.0

e9/l

0.0

2.16

4599

41412

(3024561) Albumin [Mass/volume] in Serum or Plasma

4599

41339

1.16

13.94

4.7

4.2

g/l

36.6

0.00

4321

38532

(40761511) CBC panel - Blood by Automated count

12830

124848

1.31

13.65

10.7

9.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12546

121764

1.27

13.45

12.4

11.1

umol/l

66.7

66.5

0.73

12541

121701

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6138

56463

1.14

13.16

3.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4328

38857

1.16

13.13

1.8

pmol/l

99.1

99.8

0.40

2314

20403

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1798

15016

1.22

12.80

1.7

1.6

1.4

1.3

2.05

1599

13561

(3007853) Bacteria identified in Skin by Aerobe culture

1525

12523

1.24

12.78

1.7

1.6

—

(3026782) Osmolality of Urine

2144

18304

1.19

12.03

2.9

2.4

mosm/kgh2o

508.5

520.2

1.60

1831

15542

(3048689) Calprotectin [Mass/mass] in Stool

2121

18151

1.19

11.55

2.4

2.3

ug/g

109.6

100.5

0.59

1636

14211

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11699

113077

1.19

11.09

5.2

5.1

mu/l

1.9

2.0

0.10

11068

107354

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3662

32842

1.15

10.82

2.5

2.4

u/l

53.3

56.9

6.79

3408

30475

(3018418) pH of Serum or Plasma

3159

28040

1.15

10.80

4.1

3.5

7.4

0.25

549

5361

(3044889) 12 lead EKG panel

7588

71275

1.13

10.76

3.0

2.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1433

11896

1.22

10.75

2.2

u/l

3832.1

6103.2

2.49

550

4954

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

384

2.21

10.61

1.4

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

2312

20085

1.17

10.44

2.6

2.3

e6/l

8.6

8.4

0.18

1990

17358

(3025941) Bacteria identified in Stool by Culture

990

7922

1.26

10.42

1.3

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2739

24147

1.16

10.19

1.3

u/ml

10.9

9.8

0.40

1087

10325

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8752

83059

1.13

10.15

3.0

2.8

u/l

35.6

34.5

0.76

8372

79277

(3029937) Albumin [Presence] in Urine by Test strip

3440

30860

1.14

9.97

3.9

3.6

estimate

0.0

0.51

1279

11603

(3045414) Leukocytes [Presence] in Urine

686

5279

1.31

9.86

1.8

1.7

—

(3000991) Gas panel - Venous blood

730

5704

1.29

9.36

8.2

7.8

—

(3037522) Nuclear Ab [Titer] in Serum

2203

19231

1.16

9.26

1.4

titre

563.5

576.0

0.11

479

3931

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10481

100822

1.14

9.12

4.5

4.4

pmol/l

14.4

14.3

0.11

9856

94852

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1423

12001

1.20

9.02

2.9

2.4

umol/l

5.8

6.2

0.59

1192

10033

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

995

8103

1.24

8.97

1.7

—

(3019150) Specific gravity of Urine by Refractometry

2783

24765

1.15

8.95

3.7

3.5

kg/l

1.0

0.99

390

3810

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4205

38427

1.13

8.90

3.4

3.0

u/l

30.5

29.5

0.37

4001

36725

(3023511) Choriogonadotropin [Units/volume] in Urine

773

6136

1.27

8.74

1.4

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2983

26725

1.14

8.63

2.0

u/l

150.3

142.0

0.20

2841

25253

(3007164) IgA [Mass/volume] in Serum or Plasma

3048

27349

1.14

8.61

1.4

g/l

2.2

2.1

0.72

1843

17489

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2827

25245

1.14

8.59

1.3

iu/ml

36.9

29.3

0.30

888

7979

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1204

10043

1.21

8.58

2.4

2.8

u/ml

42.0

38.2

0.13

1164

9726

(3011288) Drugs identified in Urine by Screen method

619

4802

1.29

8.42

3.6

2.8

—

(3035941) MCH [Entitic mass]

13457

132446

1.41

8.34

17.5

15.8

30.2

30.0

42.81

13341

131289

(3024731) MCV [Entitic volume]

13458

132460

1.41

8.32

17.5

15.8

90.8

90.3

39.96

13340

131305

(3026361) Erythrocytes [#/volume] in Blood

13458

132471

1.41

8.20

17.6

15.8

e12/l

4.4

4.5

16.78

13195

129908

(3022145) Colonoscopy Study observation

1407

11960

1.19

8.15

1.4

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2328

20587

1.15

8.11

1.5

nmol/l

21.8

21.1

1.23

2050

18171

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

162

2.64

8.07

1.1

1.2

—

(3010813) Leukocytes [#/volume] in Blood

13459

132500

1.40

8.01

17.6

15.9

e9/l

6.7

6.6

3.72

13199

129866

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1170

9798

1.20

8.00

2.4

2.3

u/l

37.8

36.6

0.12

985

8371

(3007461) Platelets [#/volume] in Blood

13445

132345

1.39

7.95

17.6

15.9

e9/l

269.3

269.0

0.27

13202

129957

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1286

10870

1.19

7.94

5.1

5.0

—

(3042936) Bacteria identified in Isolate by Culture

1543

13255

1.18

7.88

1.9

1.8

—

(3000963) Hemoglobin [Mass/volume] in Blood

13459

132516

1.40

7.85

17.7

15.9

g/l

133.0

132.9

0.14

13346

131365

(3028707) Methadone [Presence] in Urine by Screen method

401

2956

1.36

7.83

3.2

2.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4930

45710

1.11

7.80

3.6

3.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1917

16780

1.16

7.68

2.5

mmol/l

2.4

0.00

1641

14669

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1544

13305

1.17

7.58

1.8

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

432

3248

1.33

7.42

5.1

4.1

mmol/l

24.2

24.3

0.06

392

2905

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

546

4242

1.29

7.39

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3585

32746

1.12

7.37

1.3

u/ml

1.7

1.4

0.57

1063

9684

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1350

11536

1.18

7.35

1.5

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5353

49988

1.10

7.20

2.3

nmol/l

76.4

1832.1

0.50

4933

46687

(3013826) Glucose [Moles/volume] in Serum or Plasma

6230

58621

1.10

7.18

4.1

3.8

mmol/l

6.3

0.55

5685

52980

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1647

14333

1.16

7.12

3.2

3.0

mmol/l

0.8

2.55

1544

13410

(3005719) IgG [Mass/volume] in Serum or Plasma

1015

8495

1.20

6.99

2.7

2.5

g/l

10.4

0.11

935

7787

(3015377) Calcium [Moles/volume] in Serum or Plasma

3754

34465

1.11

6.96

3.2

3.1

mmol/l

2.3

0.24

3348

30929

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

315

2.06

6.94

3.2

2.7

—

(3014051) Protein [Presence] in Urine by Test strip

340

2494

1.36

6.90

2.0

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

794

6500

1.23

6.86

1.7

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1062

8964

1.19

6.67

6.8

6.4

mmol/l

104.6

104.8

0.54

1043

8802

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1795

15807

1.15

6.57

2.9

ng/l

169.1

283.7

2.27

980

8662

(3016879) Cocaine [Presence] in Urine

767

6300

1.22

6.43

2.6

2.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3446

31617

1.11

6.37

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

10578

102426

1.11

6.32

14.2

12.7

13.5

0.53

10392

100564

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1022

8645

1.19

6.28

1.6

—

(3002032) Base excess in Venous blood by calculation

738

6064

1.22

6.18

4.2

3.6

mmol/l

2.0

1.8

0.79

604

4939

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1035

8777

1.19

6.18

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

742

6106

1.22

6.12

4.2

3.5

kpa

5.9

5.8

0.62

722

5915

(3028300) Cannabinoids [Presence] in Urine

834

6947

1.21

6.08

2.5

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

828

6896

1.21

6.04

2.5

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11137

108222

1.12

5.99

3.7

3.6

mmol/l

5.6

0.84

10428

101687

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.86

5.95

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

507

1.75

5.89

2.7

41.2

44.7

0.50

192

(3022217) INR in Platelet poor plasma by Coagulation assay

1001

8505

1.18

5.85

14.4

13.8

inr

1.2

1.1

0.42

144

1427

(3027008) Opiates [Presence] in Urine

829

6931

1.20

5.82

2.2

1.9

—

(4198724)

104

622

1.67

5.78

4.4

2.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

301

2232

1.35

5.77

3.7

2.9

mg/l

1.4

1.3

1.30

284

2081

(1001926) Buprenorphine [Presence] in Urine by Screen method

651

5321

1.23

5.76

2.8

2.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

519

4140

1.26

5.74

1.3

u/ml

37.6

33.0

0.23

290

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

588

4757

1.24

5.74

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

130

828

1.57

5.61

2.1

2.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

237

1700

1.39

5.61

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

237

1700

1.39

5.61

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1694

15036

1.14

5.49

1.7

nmol/l

1176.1

1187.4

0.20

1354

11829

(3026389) Candida sp identified in Specimen by Organism specific culture

271

1997

1.36

5.44

1.4

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

699

5790

1.21

5.43

9.1

6.8

mmol/l

7.9

7.4

1.48

666

5578

(3019832) Treponema pallidum Ab [Presence] in Serum

2755

25181

1.11

5.37

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

369

2848

1.30

5.36

3.2

2.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

960

8195

1.18

5.32

2.4

2.2

g/l

0.2

1.05

904

7728

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10125

98076

1.10

5.31

4.4

mmol/mol

37.2

37.7

5.92

9529

92763

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2931

26895

1.11

5.28

2.2

2.1

mg/l

2.7

0.26

2513

23266

(3000494) Fungus identified in Specimen by Culture

1410

12397

1.14

5.27

1.5

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

775

6502

1.20

5.26

1.7

1.8

g/l

1.3

0.64

713

6008

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

998

8563

1.17

5.20

4.2

3.8

u/l

227.8

233.4

0.76

946

8109

(3027944) Amphetamines [Presence] in Urine

810

6834

1.19

5.17

2.4

1.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3507

32503

1.10

5.12

2.7

2.6

ng/l

24.9

51.2

0.64

1532

14695

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6791

64738

1.08

5.10

2.9

3.0

ug/l

74.9

71.0

1.32

6417

61552

(3000093) Morphology [Interpretation] in Blood Narrative

109

686

1.58

5.00

1.1

—

(3023368) Bacteria identified in Blood by Culture

2301

20906

1.11

5.00

4.0

3.7

—

(3051611) Lipemic interference index of Serum or Plasma

132

869

1.51

4.96

3.3

2.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

599

4935

1.22

4.95

3.5

3.0

kpa

4.6

0.33

577

4768

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

543

4430

1.23

4.94

6.2

6.0

mmol/l

24.6

0.05

538

4394

(3014111) Lactate [Moles/volume] in Serum or Plasma

742

6245

1.19

4.88

6.8

6.3

mmol/l

1.2

0.63

711

6039

(3032080) INR in Blood by Coagulation assay

3511

32606

1.09

4.87

5.6

5.4

inr

1.1

0.02

1108

10763

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

498

6031

0.81

4.82

1.4

—

(3022621) pH of Urine by Test strip

853

7279

1.18

4.78

2.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

549

4503

1.22

4.76

2.5

2.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

541

4431

1.22

4.76

2.1

2.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1561

13911

1.13

4.75

2.5

2.2

g/l

2.4

2.5

3.10

1420

12913

(42529406) Shigella sp [Presence] in Stool by Culture

472

3813

1.24

4.73

1.2

—

(3051651) Icteric interference index of Serum or Plasma

518

1.65

4.73

3.7

3.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

465

3759

1.24

4.64

1.2

—

(3000492) Spirometry study

1305

11516

1.14

4.63

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

470

3806

1.23

4.62

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

250

1871

1.33

4.60

6.8

5.2

iu/ml

643.6

778.7

0.20

223

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.62

4.58

7.1

10.2

mmol/l

4.4

5.1

0.92

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

262

1976

1.32

4.57

1.9

g/l

0.0

1.70

241

1820

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

426

3422

1.24

4.52

8.6

8.7

mmol/l

24.2

0.04

396

3225

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

344

2695

1.28

4.52

1.5

1.6

—

(40761535) Cells panel - Urine sediment

871

7481

1.17

4.52

3.7

3.3

—

(3017732) Neutrophils [#/volume] in Blood

1002

8704

1.16

4.47

2.5

2.3

e9/l

4.2

4.1

0.55

825

7270

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2932

27101

1.10

4.46

1.7

mg/l

0.9

0.45

2165

20195

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

512

4200

1.22

4.46

1.4

u/l

25.2

25.4

0.06

405

3464

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

675

5697

1.19

4.34

1.1

u/ml

29.4

7.6

0.51

(3015171) Extractable nuclear Ab [Units/volume] in Serum

714

6059

1.18

4.31

1.3

u/ml

1.4

1.1

0.21

518

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11658

113979

1.11

4.29

3.9

mmol/l

2.9

1.19

11007

107704

(3000570) Elastase.pancreatic [Mass/mass] in Stool

358

2838

1.26

4.28

1.3

1.4

ug/g

333.5

303.0

1.80

211

1465

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

111

729

1.52

4.28

2.7

e6/l

803.7

856.3

0.28

336

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

517

4267

1.21

4.25

2.5

1.9

g/l

1.1

1.2

2.30

490

4069

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

280

2158

1.30

4.21

2.2

2.1

g/l

0.6

0.5

0.13

249

1913

(21494815) CD4 cells/100 lymphocytes in Specimen

132

902

1.46

4.20

2.4

2.0

43.9

45.6

0.19

149

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

504

4155

1.21

4.20

2.5

1.9

g/l

0.2

1.55

475

3950

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

195

1430

1.36

4.15

1.6

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

309

2417

1.28

4.15

2.2

2.0

g/l

3.0

0.09

246

1897

(3048929) Epstein Barr virus Ab [Presence] in Serum

552

4597

1.20

4.14

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11063

107940

1.09

4.12

3.3

3.2

mmol/l

1.2

0.40

10451

102207

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

259

1983

1.30

4.10

2.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

111

737

1.50

4.08

1.5

promille

1.3

0.21

558

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

388

3125

1.24

4.06

2.0

1.9

g/l

1.5

1.4

0.85

330

2699

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3672

34405

1.08

4.01

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

928

8084

1.15

4.01

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

895

7784

1.15

3.96

6.6

kpa

13.4

13.5

0.25

848

7423

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1185

10504

1.13

3.95

6.5

4.8

mmol/l

1.0

0.04

1108

9862

(3009508) Creatinine [Moles/volume] in Urine

2795

25913

1.09

3.93

3.4

3.1

mmol/l

7.2

7.9

0.59

2398

22313

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

895

7789

1.15

3.93

6.6

6.7

kpa

5.1

5.0

0.45

852

7436

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

473

3903

1.21

3.93

1.6

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

491

1.60

3.91

1.9

2.3

umol/l

149.0

157.1

0.09

235

(3003396) Base excess in Arterial blood by calculation

895

7792

1.15

3.91

6.6

6.7

mmol/l

0.9

0.03

679

5967

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

452

3716

1.22

3.90

1.4

1.3

u/ml

14.1

5.6

1.09

399

(3004716) Salmonella sp identified in Stool by Organism specific culture

949

8303

1.15

3.86

1.5

—

(3013762) Body weight Measured

4.14

3.84

1.0

—

(3045424) Erythrocytes [Presence] in Urine

255

1968

1.29

3.83

1.5

—

(3016502) Oxygen saturation in Arterial blood

779

6724

1.16

3.83

6.9

7.1

96.2

96.3

0.09

745

6449

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

458

3778

1.21

3.83

1.4

1.3

u/ml

11.7

8.6

0.42

617

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

477

3951

1.21

3.82

1.7

1.6

iu/ml

0.1

5.0

0.56

100

732

(36660697) Celiac disease serology panel - Serum

1287

11492

1.12

3.81

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

191

1418

1.34

3.79

2.9

2.4

u/ml

562.6

12381.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

644

7441

0.85

3.77

1.7

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

316

2513

1.26

3.74

2.2

2.0

g/l

3.6

3.7

0.42

239

1825

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

316

2514

1.25

3.72

2.2

2.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1706

15498

1.11

3.70

2.5

2.2

umol/l

14.6

14.3

1.15

1568

14412

(4010399)

822

7145

1.15

3.69

1.4

—

(3019225) pH of Specimen

998

8791

1.14

3.69

3.3

3.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

316

2518

1.25

3.68

2.2

2.0

g/l

7.3

7.2

0.09

249

1938

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1405

12638

1.12

3.67

2.0

29.3

29.1

0.24

1369

12220

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

253

1970

1.28

3.58

1.7

1.9

g/l

38.7

0.04

225

1732

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1036

9167

1.13

3.57

2.3

au/ml

17.8

22.7

1.25

716

(3003181) Sodium [Moles/volume] in Urine

155

1126

1.37

3.56

1.5

1.4

mmol/l

55.1

66.6

3.28

134

881

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11532

112887

1.09

3.55

3.7

3.6

mmol/l

4.9

0.91

10987

107365

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

733

8344

0.87

3.54

1.4

1.5

—

(40768797) Stomach Pathology biopsy report

1667

15162

1.11

3.53

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

468

3902

1.20

3.52

1.6

1.5

u/ml

8.0

9.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

741

6416

1.16

3.52

7.3

7.4

g/l

119.0

120.5

1.44

719

6168

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1380

12432

1.11

3.51

2.7

2.3

24.0

23.5

0.80

1195

10726

(3003327) Ova and parasites identified in Stool by Light microscopy

601

5125

1.17

3.49

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

230

1776

1.29

3.48

1.8

1.9

g/l

0.0

0.00

211

1643

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

232

1796

1.29

3.45

1.8

1.9

g/l

0.0

0.50

212

1648

(3023323) Follitropin [Units/volume] in Serum or Plasma

1542

13987

1.11

3.45

1.3

iu/l

26.1

27.0

0.58

1348

12256

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10202

99420

1.08

3.42

3.9

3.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11467

112291

1.09

3.31

3.6

mmol/l

1.6

0.01

10878

106615

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1962

18046

1.09

3.29

2.5

2.4

ng/l

678.1

700.1

0.15

1613

14733

(3023420) DNA double strand Ab [Units/volume] in Serum

206

1582

1.30

3.28

2.2

1.6

iu/ml

32.0

33.9

0.08

(3023183) Ammonium ion [Moles/volume] in Plasma

182

1376

1.32

3.25

3.0

2.9

umol/l

32.2

33.0

0.20

163

1184

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

109

759

1.43

3.23

1.6

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

299

1.70

3.22

1.1

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

299

1.70

3.22

1.1

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

129

930

1.38

3.15

1.2

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

268

2138

1.25

3.15

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

544

1.50

3.12

2.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

172

1299

1.32

3.11

1.4

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

809

7115

1.14

3.11

1.4

1.3

miu/ml

212.0

232.8

1.04

410

3642

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

133

968

1.37

3.08

1.3

1.2

u/ml

65.7

55.0

0.21

(3042733) HLA Ab [Presence] in Serum

259

1.73

3.06

4.5

5.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

289

2334

1.24

3.05

2.1

1.9

g/l

10.0

10.1

0.15

248

1986

(3024891) Influenza virus A+B Ag [Presence] in Specimen

402

3359

1.19

3.01

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

951

8469

1.12

3.00

1.3

au/ml

28.3

41.3

1.63

344

(3041806) Other cells [#/volume] in Blood by Manual count

753

0.61

2.97

1.4

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

135

993

1.35

2.94

1.3

u/ml

16.1

59.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

318

2608

1.22

2.91

3.2

3.3

u/ml

200.6

369.5

0.71

265

2212

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

132

970

1.36

2.90

1.3

u/ml

41.7

50.8

0.23

(3010375) cycloSPORINE [Mass/volume] in Blood

372

1.58

2.85

25.7

25.5

ug/l

106.9

116.5

0.63

301

(3024928) Oxygen saturation in Venous blood

184

1422

1.29

2.85

4.2

3.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

315

2588

1.21

2.84

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

127

933

1.36

2.80

1.3

1.2

u/ml

13.5

4.1

0.73

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

381

3192

1.19

2.80

1.5

1.6

titre

421.7

302.6

0.28

143

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

125

917

1.36

2.79

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

359

1.58

2.78

1.3

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

142

1063

1.33

2.77

1.7

2.0

mg/l

22.0

23.3

0.13

294

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

393

3305

1.19

2.77

1.3

u/ml

46.0

40.3

0.31

353

(40768446) Kidney Pathology biopsy report

314

1.62

2.73

1.9

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1266

11519

1.10

2.70

3.4

3.6

32.6

32.8

0.38

956

8524

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2891

27208

1.07

2.69

1.6

mmol/l

1.4

1.3

0.39

2516

23705

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

301

2478

1.21

2.68

1.3

1.5

iu/ml

9.5

14.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

218

1740

1.25

2.62

3.1

3.0

mg/l

35.7

72.0

0.57

182

1397

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

350

2932

1.19

2.60

1.4

1.3

u/ml

2.1

3.7

0.62

228

(3016038) Potassium [Moles/volume] in Urine

421

1.51

2.60

1.4

1.2

mmol/l

32.3

33.5

0.15

367

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

169

1310

1.29

2.59

1.4

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3573

33900

1.06

2.59

3.0

2.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

11538

113244

1.08

2.58

12.6

11.3

39.6

39.5

1.08

9469

91892

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

217

1738

1.24

2.54

3.2

3.0

mg/l

29.1

35.2

0.70

182

1396

(3017354) Segmented neutrophils/100 leukocytes in Blood

104

754

1.37

2.53

3.0

2.7

58.6

56.4

0.44

491

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

336

2817

1.19

2.49

1.3

1.2

u/ml

0.7

18.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

580

5073

1.14

2.49

2.0

ug/l

5.9

5.6

0.08

511

4383

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

129

972

1.32

2.45

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

300

2497

1.20

2.42

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

877

7881

1.11

2.41

2.3

ml/min/173m2

72.9

75.5

1.06

325

2948

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

428

3676

1.16

2.38

8.4

8.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

880

7916

1.11

2.38

2.5

2.4

1.8

1.7

0.25

783

7053

(3000330) Specific gravity of Urine by Test strip

512

4458

1.15

2.36

3.1

2.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

293

2441

1.20

2.35

1.3

1.2

u/ml

294.1

260.8

1.34

209

1623

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.61

2.34

2.6

3.5

—

(3022689) Creatine [Moles/volume] in Urine

242

1.64

2.34

1.6

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

407

3488

1.16

2.34

2.3

2.4

g/l

3.7

3.6

0.90

380

3289

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

133

1015

1.30

2.33

1.2

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

358

3038

1.18

2.33

2.4

2.2

mg/l

10.0

10.3

0.39

339

2853

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

132

1010

1.30

2.28

1.2

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

355

3023

1.17

2.23

3.5

2.9

0.6

0.7

0.84

340

2896

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

106

789

1.34

2.23

6.4

mg/l

11.9

11.2

0.74

741

(44816559) Phosphatidylethanol [Mass/volume] in Blood

277

2312

1.19

2.20

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

578

5107

1.13

2.16

2.3

2.4

ng/l

156.3

116.3

1.38

510

4587

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

268

2235

1.20

2.16

2.3

2.1

ug/l

416.3

430.4

0.03

240

1980

(3004809) Band form neutrophils/100 leukocytes in Blood

157

1239

1.26

2.15

2.8

2.7

1.5

1.4

0.11

117

981

(40768441) Liver Pathology biopsy report

107

803

1.33

2.14

1.6

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

676

1.35

2.12

3.0

3.1

nmol/l

0.8

0.64

501

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

735

6598

1.11

2.10

3.9

3.3

ng/l

84.2

75.7

1.49

664

5831

(3009466) Valproate [Moles/volume] in Serum or Plasma

178

1430

1.24

2.09

4.8

5.5

umol/l

374.3

378.4

0.14

158

1246

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

304

2572

1.18

2.09

1.4

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

501

1.41

2.09

2.4

au/ml

235.5

155.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

460

4019

1.14

2.06

3.5

3.1

g/l

128.7

129.3

0.30

453

3916

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

599

5323

1.12

2.06

1.5

—

(3028433) Virus identified in Specimen by Culture

323

1.51

2.04

1.2

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

413

1.45

2.02

1.6

au/ml

162.8

132.3

0.26

(4015189)

146

1.77

2.01

2.2

2.3

—

(3037121) Protein [Mass/volume] in Urine

351

3017

1.16

1.99

3.1

2.8

g/l

0.2

0.3

1.09

139

1161

(3022493) Free Hemoglobin [Mass/volume] in Plasma

333

1.49

1.99

2.7

3.7

mg/l

3395.8

3393.1

0.00

244

(21494755) Public health laboratory ask at order entry panel

1664

17581

0.93

1.97

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.13

1.95

1.0

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.27

1.94

1.2

ml/s/173m2

8.8

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

110

843

1.30

1.93

2.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

535

4748

1.12

1.90

1.4

pmol/l

81.1

100.1

0.94

528

4629

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1131

10419

1.09

1.90

3.3

3.4

pmol/l

4.5

0.03

1001

9410

(1761868) Lipid panel - Serum or Plasma

4632

47474

0.95

1.89

2.2

2.3

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

1.88

0.0

1.1

—

14.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

693

0.69

1.86

1.1

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

634

5690

1.11

1.86

2.3

g/l

66.8

67.1

0.62

572

5252

(3005322) IgE [Units/volume] in Serum or Plasma

1057

9724

1.09

1.84

1.3

u/ml

213.0

178.5

0.42

976

9036

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

204

1688

1.20

1.84

3.1

3.0

ratio

1.2

1.8

0.71

178

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

136

1.75

1.83

5.1

6.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

431

3787

1.13

1.82

2.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

170

1384

1.22

1.81

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

372

3238

1.15

1.81

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

205

1702

1.20

1.79

2.9

2.6

mmol/l

24.6

24.5

0.25

178

1510

(3013512) EKG study

2569

24392

1.06

1.79

3.0

2.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2650

25183

1.06

1.79

2.3

2.1

umol/l

1967.3

2820.9

1.02

2360

22402

(3011648) Oxygen content in Venous blood

586

1.34

1.77

2.2

2.4

10.4

11.2

0.84

586

(3028626) Oxygen [Partial pressure] in Capillary blood

181

1489

1.21

1.75

2.9

2.4

kpa

9.0

8.7

0.58

167

1400

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

117

918

1.27

1.74

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

280

2396

1.16

1.73

1.4

1.3

u/ml

133.2

109.1

0.73

583

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.31

1.73

1.0

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

369

1.43

1.73

8.3

4.9

u/ml

49.4

1745.3

0.57

(3049717) Cytology report of Urine Cyto stain

211

1764

1.19

1.73

1.9

2.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.02

1.71

1.0

1.5

—

(3017569) Oxygen content in Arterial blood

248

1.52

1.70

2.4

2.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

590

1.33

1.70

1.7

1.6

iu/ml

3812166.7

1477063.0

—

(3023520) Reticulocytes [#/volume] in Blood

610

5494

1.11

1.70

2.4

e9/l

70.6

72.1

0.38

459

3981

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

897

8228

1.09

1.70

3.5

3.6

ug/l

15.4

21.7

0.32

675

5996

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

296

2554

1.15

1.66

1.3

u/ml

26.2

18.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.37

1.65

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.17

1.64

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

276

2371

1.16

1.64

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

316

1.45

1.63

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.08

1.62

1.3

2.7

g/mol

31.8

40.9

0.16

(3004616) Nuclear Ab [Presence] in Serum

197

1648

1.19

1.62

1.5

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

292

1.46

1.61

2.0

1.7

u/ml

407.2

1966.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

510

4567

1.11

1.60

2.6

2.3

e6/l

0.2

0.3

0.27

483

4363

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

545

1.33

1.60

2.8

2.9

mg/l

8.8

8.1

0.22

428

(21494814) CD8 cells/100 lymphocytes in Specimen

418

1.38

1.58

2.4

2.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

864

0.75

1.58

1.2

1.3

g/l

1.6

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.48

1.58

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1391

13018

1.07

1.57

1.2

iu/ml

158.0

150.7

0.23

525

5201

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

412

3650

1.13

1.57

2.2

164.1

168.4

0.56

392

3433

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

522

1.33

1.55

2.0

1.8

mg/l

8.7

9.6

0.64

414

(3013293) Extractable nuclear Ab [Presence] in Serum

238

1.50

1.55

1.7

—

(3019060) Gas panel - Arterial blood

481

4304

1.11

1.54

4.3

4.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

979

9062

1.08

1.51

1.2

—

(3003694) ABO and Rh group [Type] in Blood

4070

39239

1.04

1.51

1.6

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.26

1.51

6.6

3.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.58

1.50

1.0

1.1

nmol/l

186.5

240.0

—

(3030313) Adrenal Ab [Titer] in Serum

200

1.54

1.49

1.1

—

(3016228) CD19 cells/100 cells in Blood

423

1.36

1.49

2.4

2.0

8.1

8.2

0.02

415

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

148

1217

1.21

1.49

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

1.49

0.0

1.2

—

(3021788) Differential panel - Synovial fluid

187

1573

1.18

1.47

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

282

1.45

1.47

2.2

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

113

905

1.24

1.47

2.2

2.0

11.8

12.9

0.48

471

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

386

3427

1.12

1.44

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3035

29104

1.05

1.43

4.1

3.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

861

7951

1.08

1.43

4.0

3.8

0.7

0.01

171

1443

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

121

980

1.23

1.43

3.4

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2044

19416

1.05

1.42

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

195

1.53

1.41

1.4

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

141

1163

1.21

1.39

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

342

3022

1.13

1.39

1.2

1.3

—

(3011412) CD3 cells [#/volume] in Blood

137

1127

1.21

1.39

2.6

2.4

e9/l

1.3

0.09

655

(3010503) CD19 cells [#/volume] in Blood

637

1.28

1.39

3.0

2.6

e9/l

0.2

0.12

625

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

212

1.50

1.39

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

141

1164

1.21

1.38

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

898

8320

1.08

1.38

4.2

4.0

0.1

0.2

1.26

218

1817

(3010144) Erythrocytes [#/volume] in Synovial fluid

744

1.26

1.37

1.4

1.5

e6/l

20262.3

49193.4

0.77

505

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

141

1166

1.20

1.36

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

933

8663

1.08

1.36

4.1

4.0

0.7

0.9

1.29

231

1956

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

1.32

0.0

8.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

212

1823

1.16

1.31

2.2

2.0

g/l

129.9

130.7

0.20

148

1346

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1242

11663

1.06

1.30

2.0

2.1

nmol/l

382.2

374.3

0.73

1152

10759

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

142

1182

1.20

1.30

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

142

1182

1.20

1.30

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

119

974

1.22

1.29

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

142

1184

1.19

1.28

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.76

1.27

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

166

1404

1.18

1.27

1.1

g/l

1.5

0.24

154

1277

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

158

1332

1.18

1.26

1.4

—

(3008898) HLA-B27 [Presence]

708

6527

1.08

1.26

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

673

1.26

2.2

2.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

209

1.47

1.26

1.0

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2366

22633

1.05

1.25

4.1

3.9

mg/mmol

11.1

9.5

0.61

1435

13788

(3005988) Vibrio sp identified in Specimen by Organism specific culture

158

1334

1.18

1.24

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

215

1860

1.15

1.24

1.4

1.3

u/ml

52.5

49.3

0.06

128

(3025159) Blasts/100 leukocytes in Blood

859

7985

1.07

1.23

4.2

4.1

0.1

0.3

0.85

183

1564

(3052592) Norovirus Ag [Presence] in Stool

154

1.55

1.22

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

474

4302

1.10

1.22

3.4

2.9

kpa

5.1

0.39

439

4005

(3021901) Oxygen saturation in Capillary blood

145

1218

1.18

1.22

3.0

2.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

222

2515

0.87

1.20

1.6

mmol/l

7.6

0.00

138

1548

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

113

929

1.21

1.20

1.4

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

531

4849

1.09

1.20

2.2

2.1

u/l

39.5

39.7

0.06

494

4489

(3012494) Peanut IgE Ab [Units/volume] in Serum

493

1.29

1.19

1.1

u/ml

2.7

1.8

0.23

270

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

206

1783

1.15

1.19

3.0

3.5

u/ml

0.4

0.26

102

1011

(3024522) Salmonella sp identified in Specimen by Organism specific culture

159

1350

1.17

1.18

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

157

1332

1.17

1.18

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

155

1314

1.17

1.18

3.5

3.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

106

868

1.21

1.17

1.1

1.2

titre

24.3

202.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

556

1.27

1.17

1.5

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

274

2423

1.13

1.15

1.5

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

576

1.26

1.14

3.8

3.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

220

1923

1.14

1.12

2.5

2.6

—

(3012516) Albumin [Mass/volume] in Urine

2260

21656

1.04

1.12

3.5

3.2

mg/l

412.4

503.2

0.39

1376

12916

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

106

874

1.21

1.11

1.1

1.2

titre

301.1

171.3

0.64

165

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

232

1.41

1.11

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

758

1.22

1.10

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

470

4290

1.09

6.1

6.5

mmol/l

24.4

24.5

0.20

439

3963

(4211845)

624

1.24

1.09

2.6

—

(3006462) Nitrate [Presence] in Urine

562

1.26

1.09

2.6

2.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

119

1.59

1.08

1.6

2.1

u/field

0.6

0.9

0.55

119

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

135

1.55

1.08

6.0

4.8

ug/min

42.6

34.9

0.35

(3024471) HLA-A [Type]

284

1.37

1.08

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

484

1.27

1.07

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

158

1355

1.16

1.06

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

450

4107

1.09

1.06

3.4

2.8

mmol/l

1.6

1.5

0.25

327

2913

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

771

1.21

1.05

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

167

1441

1.15

1.04

1.5

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1615

16728

0.95

1.04

1.4

1.5

—

(3020891) Body temperature

303

2716

1.11

1.04

4.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

602

1.24

1.03

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

105

1.61

1.03

1.0

1.1

umol/24h

1.6

1.5

0.16

105

(3000034) Microalbumin [Mass/volume] in Urine

738

1.21

1.02

2.9

2.6

mg/l

147.6

48.4

0.69

502

(3020961) Endomysium IgA Ab [Titer] in Serum

821

7682

1.07

1.02

1.1

titre

195.3

186.8

0.03

188

(4268621)

182

1584

1.14

1.01

2.2

2.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

135

1149

1.17

1.01

2.0

u/ml

147.6

1397.2

0.72

123

999

(4281824)

178

1547

1.15

1.01

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

367

3992

0.91

1.01

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

581

5372

1.08

1.01

1.6

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

409

1.29

1.01

1.2

pmol/l

17.7

17.4

0.06

374

(3018738) Hemoglobin F/Hemoglobin.total in Blood

105

0.47

1.01

1.2

1.5

—

15.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

249

0.64

1.00

1.8

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

948

8915

1.06

1.00

2.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

160

1382

1.15

1.00

1.5

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.99

0.99

1.1

—

(4062490)

148

1272

1.16

0.99

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

131

1116

1.17

0.98

1.2

u/l

54.9

57.8

0.32

748

(3014148) Varicella zoster virus Ab [Titer] in Serum

256

2283

1.12

0.98

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.97

0.0

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

121

1025

1.17

0.97

1.5

—

(4094501)

254

2265

1.12

0.97

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

222

1.39

0.97

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

465

1.26

0.97

1.2

1.3

—

(3007916) DNA double strand Ab [Titer] in Serum

172

1.44

0.96

1.0

1.5

—

140.8

—

(3009343) pH of Capillary blood

463

4253

1.08

0.96

3.4

2.8

7.4

0.30

592

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.93

0.96

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

386

0.72

0.96

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

663

1.22

0.95

1.6

u/l

9.3

5.0

0.56

310

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

240

2137

1.12

0.95

1.5

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

125

1065

1.17

0.95

1.1

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

791

1.19

0.94

2.1

1.7

101.6

0.00

703

(3019977) pH of Arterial blood

344

1.30

0.94

2.4

2.8

7.4

0.26

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

468

1.25

0.93

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

155

1347

1.14

0.91

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

125

1.51

0.91

1.3

2.2

—

(40768443) Skin Pathology biopsy report

506

4680

1.08

0.90

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

304

2752

1.10

0.89

1.3

e6/l

77.1

20.7

0.71

230

2129

(3007463) Buprenorphine [Presence] in Urine

1.66

0.89

13.4

7.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

312

1.31

0.89

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1829

18814

0.96

0.89

2.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

127

0.55

0.88

3.0

2.9

u/l

505.9

2616.3

—

119

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

287

0.69

0.88

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

304

2757

1.10

0.87

1.4

e6/l

13130.4

1424.9

0.46

240

2239

(3042111) Morphology [Interpretation] in Bone marrow Narrative

115

982

1.16

0.87

1.6

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

671

1.20

0.86

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

305

1.30

0.86

2.3

1.9

—

(3047189) Immunofixation for 24 hour Urine

236

1.35

0.86

1.8

1.9

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

787

0.82

0.86

14.0

16.9

nmol/l

1443.8

3646.1

0.82

750

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

763

1.19

0.85

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

101

855

1.17

0.85

3.2

2.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1112

11553

0.95

0.85

1.7

—

(3019174) dRVVT (LA screen)

152

1.44

0.85

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

285

0.70

0.85

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

144

1.45

0.84

1.1

1.5

ng/l

93.6

54.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

574

1.21

0.84

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.92

0.84

1.0

—

(3022313) Gas panel - Capillary blood

321

2927

1.09

0.83

3.5

3.0

—

(3020650) Glucose [Presence] in Urine

369

1.27

0.82

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

387

1.26

0.82

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

307

2796

1.09

0.82

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.86

0.81

1.5

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

291

1.30

0.81

2.0

2.1

ug/min

2.9

70.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

748

0.82

0.80

11.4

12.0

nmol/l

843.0

845.4

0.01

723

(3028192) IgG subclass 2 [Mass/volume] in Serum

145

1269

1.14

0.80

1.3

1.4

g/l

2.7

3.0

1.22

103

893

(3027135) IgG subclass 1 [Mass/volume] in Serum

145

1270

1.14

0.79

1.3

1.4

g/l

7.1

6.5

0.96

103

896

(3024139) IgG subclass 3 [Mass/volume] in Serum

145

1270

1.14

0.79

1.3

1.4

g/l

0.4

0.03

104

900

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

919

0.84

0.79

6.2

6.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

345

1.27

0.79

3.7

3.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

147

0.61

0.78

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

1.81

0.78

6.5

2.0

—

(3009754) Celery IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

0.1

—

(3008295) Osmolality of Serum or Plasma

101

863

1.16

0.78

1.5

1.6

mosm/kgh2o

279.2

280.8

0.28

681

(3008116) Ketones [Moles/volume] in Urine by Test strip

189

1.37

0.78

1.7

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

306

2795

1.09

0.78

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

147

1.42

0.77

1.4

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

338

3102

1.08

0.77

1.3

mg/l

522.6

454.1

0.60

324

2967

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

772

1.17

0.77

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

222

1998

1.11

0.77

1.7

e6/l

6725.0

8815.4

1.14

169

1473

(3024932) HLA-DR beta [Type]

276

1.30

0.77

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

353

3246

1.08

0.77

1.3

titre

101.8

147.5

0.54

308

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

106

1.50

0.76

1.2

2.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

599

1.20

0.76

1.2

u/l

32.2

17.4

0.59

521

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.55

0.76

1.4

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

709

0.83

0.75

1.9

2.0

mmol/l

105.5

105.8

0.21

703

(3041354) Potassium [Moles/volume] in Venous blood

709

0.83

0.75

1.9

2.0

mmol/l

4.0

3.9

0.26

703

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

839

1.16

0.75

2.8

2.5

e9/l

0.2

0.17

703

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

134

1174

1.14

0.74

1.4

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

821

1.16

0.74

1.6

2.0

32.5

32.3

0.21

816

(3023410) Appearance of Cerebral spinal fluid

148

1305

1.13

0.74

1.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.07

0.74

1.4

1.2

—

(4034850)

381

3521

1.08

0.74

8.1

7.3

—

(3044009) aPTT.lupus sensitive (LA screen)

157

1.39

0.74

1.0

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.66

0.74

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.51

0.73

1.7

1.9

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

529

1.20

0.73

1.9

2.0

ug/l

54.3

20.1

0.90

520

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

648

1.18

0.73

1.5

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

214

1930

1.10

0.73

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

124

1083

1.14

0.73

1.0

—

(3002619) Bacteria identified in Specimen by Culture

209

1.33

0.72

1.4

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.99

0.72

1.4

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

108

0.55

0.72

1.2

1.4

21.2

25.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

263

0.72

0.71

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

613

1.18

0.71

1.2

u/l

85.1

81.7

0.12

547

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.74

0.71

1.1

1.0

—

(3039000) Anion gap in Blood

183

1641

1.11

0.70

5.5

6.0

mmol/l

11.0

11.1

0.02

165

1472

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.91

0.70

2.2

2.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

854

1.15

0.70

2.8

2.5

e6/l

556.6

512.4

0.55

699

(3018572) Chloride [Moles/volume] in Blood

183

1642

1.11

0.69

5.5

6.0

mmol/l

105.8

105.6

0.34

165

1473

(3027273) Bicarbonate [Moles/volume] in Venous blood

334

3081

1.08

0.69

3.1

2.9

mmol/l

25.5

25.3

0.64

324

2974

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

343

1.25

0.69

3.6

2.7

ng/l

133.1

88.2

0.34

166

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

143

0.63

0.69

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

222

2015

1.10

0.68

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

118

0.59

0.67

1.3

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

746

1.16

0.67

1.1

u/ml

7.6

10.6

0.35

125

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

254

2321

1.09

0.67

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

167

0.65

0.67

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.53

0.66

1.0

u/ml

0.1

2.8

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.62

0.66

1.1

1.3

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.77

0.65

1.0

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

222

1.30

0.65

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

117

1028

1.13

0.65

1.2

—

(3044941) Cell count panel - Synovial fluid

145

1292

1.12

0.64

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

223

0.71

0.64

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

630

1.17

0.63

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

1058

1.13

0.63

1.5

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

130

0.61

0.63

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

330

1.24

0.63

2.3

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

292

2694

1.08

0.63

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

512

1.18

0.62

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

441

4131

1.06

0.61

2.2

2.0

iu/l

33.1

9.9

0.38

190

1712

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

358

1.22

0.61

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

186

0.69

0.61

1.2

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

413

3863

1.06

0.61

2.0

94.1

95.6

0.67

379

3514

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.59

0.61

1.8

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

691

0.85

0.60

1.9

2.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

720

7479

0.95

0.60

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

377

1.21

0.60

1.4

—

(3025315) Body weight

1.54

0.60

5.1

3.9

—

(3047181) Lactate [Moles/volume] in Blood

276

2546

1.08

0.60

4.6

4.8

mmol/l

1.2

0.33

247

2241

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.60

0.0

1.1

—

0.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

514

1.18

0.60

1.2

1.4

pmol/l

13.7

13.6

0.10

428

(3050794) Legionella sp Ab [Presence] in Serum

1.58

0.60

1.0

1.2

—

(4212803)

1.56

0.60

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.60

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

848

1.14

0.60

3.4

3.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

162

0.67

0.59

1.0

u/ml

0.8

0.4

—

(44813793)

127

1130

1.12

0.59

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

303

2810

1.07

0.58

4.7

4.5

1.8

1.7

0.42

282

2617

(3008037) Lactate [Moles/volume] in Venous blood

122

1352

0.90

0.58

2.4

2.5

mmol/l

1.4

0.02

122

1318

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

422

3958

1.06

0.58

1.2

—

(3005033) Fetal Nuchal fold Thickness US

720

7468

0.96

0.58

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.50

0.58

1.5

1.3

nmol/l

294.7

526.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

0.60

0.57

1.0

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

777

1.14

0.57

1.4

1.5

umol/l

23.7

26.2

0.37

747

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

589

0.84

0.56

1.1

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

113

1253

0.90

0.55

2.5

2.6

mmol/l

7.0

7.2

0.25

113

1225

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

193

0.72

0.54

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

193

2082

0.92

0.54

3.5

3.2

mg/l

24.2

23.3

0.10

1246

(3028717) Thiamine [Mass/volume] in Blood

141

1.34

0.54

1.3

1.2

—

(3045716) Anion gap in Serum or Plasma

310

1.22

0.54

5.4

2.5

mmol/l

9.5

9.3

0.14

231

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

292

1.23

0.54

2.4

2.5

—

(3020393) Adenovirus Ag [Presence] in Stool

1.44

0.53

1.1

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

104

922

1.12

0.53

1.7

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

258

2389

1.07

0.53

1.3

1.2

u/ml

2.8

3.2

0.20

762

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

148

1614

0.91

0.53

1.3

1.5

mmol/l

9.2

11.1

1.94

213

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

586

1.15

0.53

1.1

101.3

100.3

0.10

250

(3033923) Metanephrine [Moles/time] in 24 hour Urine

212

1.27

0.53

1.0

1.1

umol/24h

0.6

0.07

104

(3020491) Glucose [Moles/volume] in Blood

104

923

1.12

0.53

1.4

1.6

mmol/l

5.8

6.0

0.29

724

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

163

1768

0.91

0.52

3.5

2.7

nmol/l

0.9

0.16

139

1499

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.53

0.52

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

105

933

1.12

0.52

1.1

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

466

0.83

0.52

2.3

2.1

ug/l

1.5

1.3

0.25

446

(3038177) Helicobacter pylori Ab [Presence] in Serum

282

2623

1.07

0.52

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

412

1.18

0.52

1.0

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

223

2057

1.08

0.52

3.5

4.1

mmol/l

3.7

3.8

0.21

209

1939

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

188

1723

1.09

0.51

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

710

1.13

0.51

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

377

1.19

0.50

2.5

2.3

umol/l

14.5

15.2

—

(3034426) Prothrombin time (PT)

469

1.17

0.50

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

368

1.19

0.50

1.4

—

(3048879) Bone marrow aspiration report

155

0.70

0.49

2.2

2.3

—

(3015183) Erythrocyte sedimentation rate

102

909

1.12

0.49

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

278

0.79

0.49

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

470

1.16

0.49

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

278

2593

1.07

0.48

1.4

1.3

—

(3037756) Immunofixation for Serum or Plasma

127

1147

1.10

0.48

2.0

1.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.51

0.48

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

856

8218

1.04

0.48

1.5

1.6

mu/l

288.1

313.0

1.25

772

7289

(3043238) Trisomy 21 risk [Likelihood] in Fetus

743

7657

0.96

0.47

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

155

1416

1.09

0.47

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

297

2781

1.06

0.47

4.8

4.6

0.9

3.12

279

2594

(3024980) IgG subclass 4 [Mass/volume] in Serum

208

1924

1.08

0.47

1.4

1.5

g/l

0.5

0.6

0.49

157

1458

(3010838) Calcium [Moles/time] in 24 hour Urine

566

0.86

0.46

1.6

mmol/24h

4.6

5.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

819

1.12

0.46

1.8

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

262

1.21

0.46

1.1

1.2

u/l

12.0

11.6

0.09

239

(3035933) Granulocytes/100 leukocytes in Blood

418

1.17

0.45

1.5

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

143

1305

1.09

0.45

1.7

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

290

1.20

0.45

1.4

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

336

1.18

0.44

1.1

93.2

88.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

164

1.27

0.44

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

146

1335

1.09

0.44

1.1

1.2

mg/l

34.2

37.6

0.59

115

1121

(4027681)

119

1078

1.10

0.44

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

161

1480

1.08

0.43

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

225

2384

0.94

0.43

1.3

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

147

1.28

0.43

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

359

0.83

0.43

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

255

1.21

0.43

1.4

—

(3010421) pH of Blood

227

2115

1.07

0.43

3.9

2.8

7.4

0.15

181

1771

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

283

2656

1.06

0.43

3.6

3.0

mmol/l

24.8

0.02

270

2467

(3029612) Listeria sp Ab [Titer] in Serum

1.45

0.42

1.8

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

608

1.13

0.42

1.1

119.7

116.5

0.28

539

(3036489) Thrombin time

468

4453

1.05

0.42

1.9

20.8

20.7

0.19

395

3675

(40768806) Pleura Pathology biopsy report

433

0.85

0.42

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

394

1.16

0.42

1.2

21.8

18.0

0.14

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

292

2746

1.06

0.42

1.2

mmol/l

3.5

3.6

0.70

280

2571

(3011048) Pyruvate [Moles/volume] in Blood

0.63

0.41

1.7

1.5

umol/l

93.3

75.7

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.63

0.41

1.0

—

(3027020) Pear IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

367

1.16

0.41

1.3

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.41

0.0

1.0

—

5.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

154

1418

1.08

0.41

1.2

1.3

—

(4024509)

104

941

1.10

0.41

1.4

1.5

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.40

0.0

1.0

—

0.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

368

1.16

0.40

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

280

0.82

0.40

1.2

1.3

nmol/l

181.7

109.7

0.87

218

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

280

0.82

0.40

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1094

11155

0.97

0.40

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

344

0.84

0.39

2.4

1.9

—

(3000060) B lymphocytes [#/volume] in Blood

406

1.15

0.39

1.9

2.1

e6/l

236.0

185.7

0.28

216

(3036782) Glucose [Moles/volume] in Pleural fluid

462

1.14

0.39

1.2

mmol/l

6.2

0.01

432

(3009677) Dengue virus Ab [Presence] in Serum

1.30

0.39

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

240

1.20

0.39

1.6

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

556

1.13

0.39

1.1

1.2

u/l

23.7

17.1

0.69

446

(40768793) Breast Pathology biopsy report

378

3929

0.95

0.39

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

481

1.14

0.39

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

123

1.29

0.39

1.4

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

268

1.19

0.38

1.3

1.2

nmol/l

0.4

0.28

183

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

168

1.24

0.38

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

501

1.13

0.38

1.2

1.4

u/ml

12.6

19.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

851

1.10

0.37

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

101

1096

0.91

0.37

1.2

u/ml

0.1

0.9

2.80

413

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

170

1579

1.07

0.37

1.2

1.3

nmol/l

0.5

1.5

0.76

164

1530

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

113

1033

1.09

0.37

1.0

1.1

iu/ml

7.2

8.6

0.37

307

(3013005) Retinol [Moles/volume] in Serum or Plasma

615

1.12

0.37

1.8

1.6

umol/l

2.0

1.9

0.48

575

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.28

0.36

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

468

0.87

0.36

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

625

0.89

0.35

1.3

1.5

nmol/l

123.8

132.5

1.02

625

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

141

1304

1.08

0.35

1.0

1.1

mg/l

198.3

208.7

0.61

121

1148

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

117

1074

1.08

0.35

1.7

1.6

46.8

48.6

0.19

669

(3017704) Immunofixation for Urine

289

1.17

0.35

2.4

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

459

4392

1.04

0.35

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.39

0.35

1.0

1.9

—

(40761536) Microorganisms panel - Urine sediment

1095

10628

1.03

0.34

3.8

3.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

133

0.75

0.34

1.2

1.1

—

(3004451) EKG impression Narrative

253

1.18

0.34

1.3

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

144

0.76

0.34

2.8

2.2

mmol/l

5.4

6.6

—

(3010937) Rubella virus Ab [Presence] in Serum

155

0.77

0.34

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

496

1.12

0.34

1.2

1.1

—

(40763590) HLA-DQ beta [Type]

1.35

0.34

1.0

—

(40760410) HLA-B [Type] by High resolution

1.35

0.34

1.0

—

(40760409) HLA-A [Type] by High resolution

1.35

0.34

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.35

0.34

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

228

2147

1.06

0.34

3.1

2.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

714

1.10

0.34

1.6

1.4

u/l

4.7

5.2

0.96

604

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.32

0.33

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

808

0.91

0.33

1.3

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

338

1.15

0.33

1.1

70.1

72.4

—

(3013862) HLA-DP [Type]

1.30

0.33

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

555

1.11

0.32

1.3

u/l

154.0

237.0

2.09

520

(3037556) Urate [Mass/volume] in Serum or Plasma

209

1.19

0.32

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.27

0.32

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

414

1.13

0.32

1.1

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

104

956

1.08

0.32

1.3

mmol/l

2.2

1.9

0.90

895

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

104

956

1.08

0.32

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

147

1556

0.94

0.31

4.1

4.4

u/ml

93.9

114.6

0.16

485

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.34

0.31

2.1

2.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

174

0.80

0.30

2.8

2.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

146

1.23

0.30

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.30

0.30

2.9

1.8

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

429

0.88

0.30

1.1

u/ml

61.5

55.8

0.21

421

(3015076) Soybean IgE Ab [Units/volume] in Serum

113

1045

1.07

0.30

1.0

u/ml

0.4

0.3

0.29

136

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

141

0.77

0.30

1.8

1.9

—

(3005570) Glucose [Moles/volume] in Urine

115

1065

1.07

0.30

1.8

2.0

—

0.8

—

(44790049)

108

998

1.08

0.30

1.4

1.5

—

(44806118)

108

998

1.08

0.30

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

620

6336

0.97

0.30

1.7

1.6

mg/l

3.0

3.4

1.19

421

4352

(44790048)

108

999

1.07

0.29

1.4

1.5

—

(44790047)

108

999

1.07

0.29

1.4

1.5

—

(40758292) HTLV I+II Ab panel - Serum

156

1.21

0.29

1.2

1.3

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.24

0.29

1.0

1.3

ug/g

256.7

153.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.32

0.29

2.0

2.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

106

0.75

0.29

12.6

11.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

598

1.10

0.28

1.1

103.3

96.3

1.52

252

(3051593) INR in Capillary blood by Coagulation assay

226

0.84

0.28

2.5

7.4

—

(40765096) Chromosome analysis panel by Banding

184

1.19

0.28

1.1

—

(3042517) Benzodiazepines panel - Urine

221

1.17

0.28

3.3

2.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.28

0.28

1.8

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

102

1.27

0.28

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

215

0.83

0.28

1.0

1.3

mg/l

0.8

79.4

1.66

156

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

268

0.85

0.28

1.1

u/ml

0.0

0.1

0.67

161

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

561

1.10

0.28

1.1

1.2

u/l

81.5

74.5

0.47

462

(3004775) Volume in Urine collected for unspecified duration

488

0.90

0.27

2.6

2.3

569.8

607.8

0.37

381

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.24

0.27

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

255

2642

0.96

0.27

1.1

u/ml

2.7

2.8

0.04

144

1426

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

160

0.81

0.27

1.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

103

1.25

0.27

1.0

1.1

u/ml

0.1

21.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

178

1860

0.95

0.27

1.3

1.4

nmol/l

29.6

31.7

0.52

168

1696

(3009214) Lutropin [Units/volume] in Serum or Plasma

500

4825

1.03

0.26

1.2

u/l

12.4

12.5

0.04

424

4019

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

112

1043

1.07

0.26

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

213

0.84

0.26

1.2

1.3

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.70

0.26

1.2

1.1

mg/l

0.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

156

1634

0.95

0.26

1.4

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

202

0.84

0.26

1.3

g/l

36.5

39.0

—

107

(3017446) Testosterone [Moles/volume] in Serum or Plasma

188

1959

0.95

0.26

1.4

1.3

nmol/l

1.4

0.11

163

1618

(3006245) CD3-CD19+ cells/100 cells in Blood

526

1.10

0.26

2.1

2.2

8.0

9.0

0.31

496

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

122

1.22

0.25

1.1

—

(3017509) Phencyclidine [Presence] in Urine

196

1.17

0.25

1.7

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

212

0.84

0.25

1.0

u/ml

0.4

0.1

—

116

(3001556) Androgen free Index in Serum or Plasma

212

0.84

0.25

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

238

2269

1.04

0.25

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

338

0.88

0.25

2.3

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

338

0.88

0.25

2.3

1.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.19

0.24

1.2

1.0

u/l

18.7

10.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

110

1028

1.06

0.24

1.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

211

0.85

0.24

1.1

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

165

1561

1.05

0.24

1.1

93.1

93.6

0.08

156

1470

(37021550) Renin [Units/volume] in Plasma --upright

225

1.15

0.24

1.3

1.4

mu/l

44.7

72.4

0.75

183

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.71

0.24

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

221

0.85

0.23

1.5

1.4

35.0

45.5

0.47

146

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

144

1359

1.05

0.23

1.6

1.4

pmol/l

348.1

375.9

0.27

112

1070

(3011985) Renin [Units/volume] in Plasma

156

1476

1.05

0.23

2.1

1.7

mu/l

58.6

53.6

0.12

143

1339

(40765089) Chromosome analysis panel - Blood by G-banded

554

0.91

0.23

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

770

0.93

0.23

1.1

miu/ml

1510.3

1489.8

0.05

770

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

146

0.82

0.23

2.0

1.5

mg/l

0.2

1.0

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

146

0.82

0.23

2.0

1.5

mg/l

1.2

0.9

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

146

0.82

0.23

2.0

1.5

mg/l

0.9

2.4

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

146

0.82

0.23

2.0

1.5

mg/l

2.0

2.4

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

146

0.82

0.23

2.0

1.5

mg/l

3.1

4.2

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

146

0.82

0.23

2.0

1.5

mg/l

7.8

1.9

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

146

0.82

0.23

2.0

1.5

mg/l

1.3

1.9

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

146

0.82

0.23

2.0

1.5

mg/l

4.2

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

741

1.07

0.23

1.0

1.1

nmol/l

0.3

6.8

1.60

134

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

454

1.09

0.22

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

359

1.11

0.22

1.2

108.7

107.6

0.10

336

(3012441) Differential panel - Pleural fluid

388

1.10

0.22

1.4

1.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

303

0.89

0.22

1.0

1.1

u/ml

3.3

0.6

0.38

212

(3034891) Synovial lining cells/100 cells in Synovial fluid

438

0.91

0.21

1.6

1.5

3.8

4.8

0.35

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

135

1276

1.05

0.21

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

122

1150

1.05

0.21

1.0

1.1

u/ml

0.3

1.3

1.70

297

(3018001) Oat IgE Ab [Units/volume] in Serum

134

1.19

0.21

1.0

u/ml

0.1

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

582

0.92

0.21

1.2

1.1

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

12.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.3

—

0.6

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.21

0.0

1.2

—

7.1

—

(3006598) pH of Arterial cord blood

1.18

0.21

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

216

2229

0.96

0.21

1.1

117.7

121.0

0.85

196

2021

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

457

4657

0.97

0.21

1.1

u/ml

5.8

4.4

0.22

719

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

899

1.06

0.21

1.1

mg/l

308.9

303.3

0.37

800

(3023430) Cat dander IgE Ab [Units/volume] in Serum

253

2602

0.97

0.21

1.1

u/ml

3.5

4.7

0.65

1036

(3051101) Glucose [Moles/volume] in Cord blood

104

0.76

0.21

2.0

4.4

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.20

0.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

144

1.17

0.20

2.5

2.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

242

2322

1.04

0.20

1.3

1.2

u/ml

2.8

4.0

2.47

114

957

(3018291) Platelet Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3003338) MCHC [Mass/volume]

10673

105792

1.01

0.20

15.0

13.2

g/l

332.0

331.6

3.99

10603

105055

(3001893) Eosinophils/100 leukocytes in Pleural fluid

111

0.81

0.20

1.2

1.4

1.9

3.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

196

0.86

0.20

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

173

1789

0.96

0.19

1.1

iu/ml

103.1

5904.4

0.63

456

(3034770) Mitochondria Ab [Titer] in Serum

334

3227

1.03

0.19

1.3

titre

1117.2

825.6

0.42

126

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

392

1.09

0.19

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

402

1.09

0.18

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

101

953

1.05

0.18

1.3

1.2

u/l

27.5

29.3

0.05

839

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

114

1080

1.05

0.18

1.1

ratio

1.1

0.09

392

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

847

1.06

0.18

1.6

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

336

1.09

0.18

1.8

1.6

ug/l

7.8

8.5

0.72

336

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

336

1.09

0.18

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

329

0.91

0.17

3.0

2.9

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

654

1.06

0.17

1.4

1.2

56.1

69.1

0.67

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

173

1657

1.04

0.17

1.2

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

769

0.94

0.17

1.0

1.1

91.4

92.6

0.12

617

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.76

0.17

1.4

2.3

umol/l

46.2

46.6

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.74

0.17

1.0

1.3

—

22.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.74

0.17

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

172

0.87

0.16

8.7

5.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.71

0.16

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.71

0.16

4.8

6.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

269

2747

0.97

0.16

1.1

u/ml

2.9

4.7

0.81

1008

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

226

2314

0.97

0.16

2.3

2.0

ug/l

2.9

1.7

0.58

193

2049

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.14

0.16

1.4

1.6

umol/24h

322.3

318.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

440

0.93

0.16

2.0

1.7

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

583

0.94

0.16

1.1

1.0

u/ml

11.8

8.8

—

(3032057) Clostridioides difficile [Presence] in Stool

176

1.13

0.16

1.8

1.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.12

0.16

1.3

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

127

1212

1.04

0.16

1.1

1.0

—

(40757373) Influenza virus identified in Isolate

171

0.87

0.15

1.3

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

171

0.87

0.15

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

110

1141

0.96

0.15

1.2

1.1

—

(3024263) Appearance of Synovial fluid

429

0.93

0.15

2.1

1.9

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

150

0.86

0.15

2.0

1.6

mg/l

1.5

2.1

—

(3045788) Cell count panel - Pleural fluid

387

1.08

0.15

1.4

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

250

2552

0.97

0.15

3.5

3.6

u/ml

32.8

31.1

0.10

236

2457

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

687

1.06

0.15

1.8

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

687

1.06

0.15

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

687

1.06

0.15

1.8

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.15

0.15

2.7

3.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

922

9042

1.01

0.15

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

234

1.10

0.15

1.2

1.6

ug/l

0.5

0.4

0.48

160

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

552

1.06

0.15

1.5

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

552

1.06

0.15

1.5

1.6

u/field

2.3

2.1

0.06

401

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

438

0.93

0.15

2.0

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

438

0.93

0.15

2.0

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

438

0.93

0.15

2.0

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

977

9588

1.01

0.14

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

211

0.89

0.14

1.5

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

923

9061

1.01

0.14

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

863

0.96

0.13

1.1

1.2

u/ml

25.4

14.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

918

9012

1.01

0.13

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

436

0.93

0.13

2.8

2.5

umol/l

51.2

49.6

0.15

367

(3028308) Erythrocytes [#/volume] in Pleural fluid

436

0.93

0.13

1.4

e6/l

18973.6

52385.6

0.98

247

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

150

1.13

0.13

1.6

2.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

150

1.13

0.13

1.4

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

799

1.04

0.13

1.6

38.3

39.9

0.14

486

(4306422)

230

2341

0.98

0.12

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

719

0.95

0.12

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

122

1.14

0.12

1.1

—

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

363

0.93

0.12

3.2

2.9

umol/l

30.1

28.0

0.95

276

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

196

1897

1.03

0.12

1.7

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

167

1613

1.03

0.12

2.7

2.1

16.9

16.8

0.14

788

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

266

1.08

0.12

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

353

1.07

0.12

1.5

1.2

nmol/l

6.2

5.6

0.49

331

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

542

5462

0.99

0.12

2.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

142

1369

1.03

0.12

3.9

u/ml

39.5

43.7

0.12

142

1364

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

136

0.88

0.11

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

922

9067

1.01

0.11

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

115

0.86

0.11

11.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

123

1.13

0.11

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

146

0.88

0.11

2.2

2.0

mmol/l

1.2

1.00

137

(3047007) Chlamydophila sp Ab [Presence] in Serum

235

2285

1.02

0.11

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

202

1961

1.02

0.11

1.6

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

862

1.04

0.11

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

391

0.94

0.11

1.0

ng/l

29.7

41.9

2.30

283

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

362

3656

0.98

0.11

1.1

u/ml

1.3

0.02

134

1344

(44806420)

114

1.13

0.11

2.5

2.1

—

(4146454)

654

0.96

0.10

2.7

2.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

404

1.06

0.10

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

379

3708

1.02

0.10

2.0

2.2

umol/l

4.5

5.3

1.27

277

2649

(3044007) Cell count panel - Peritoneal fluid

186

0.91

0.10

3.5

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

259

1.07

0.10

4.4

4.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

485

4756

1.01

0.10

2.3

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.16

0.10

1.2

1.1

u/l

128.2

271.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.16

0.10

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

571

1.04

0.10

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

854

0.97

0.09

2.9

3.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

245

2479

0.98

0.09

1.5

mmol/l

7.1

6.7

0.88

174

1799

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2091

20882

0.99

0.09

1.6

pmol/l

47088635.4

40024719.2

0.20

1803

18119

(1616796) Gas panel - Central venous blood

176

1786

0.98

0.09

4.1

2.7

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

106

1.12

0.09

3.7

3.0

pmol/l

36.7

64.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.10

0.09

1.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.08

0.08

1.0

1.4

83.7

69.2

—

(3035880) pH of Pleural fluid

222

1.07

0.08

1.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

179

1815

0.98

0.08

3.9

3.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

133

0.90

0.08

1.2

1.1

—

(21494434) Karyotype in Bone marrow

515

1.04

0.08

1.1

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.79

0.08

1.0

u/ml

0.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1026

10265

0.99

0.08

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

223

1.07

0.08

2.8

2.1

e6/l

445.1

756.2

0.74

140

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.04

0.08

1.4

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.04

0.08

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

614

1.04

0.08

1.2

g/l

0.3

0.75

487

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.83

0.07

1.0

1.1

—

4.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

487

1.04

0.07

1.3

1.4

e6/l

9474.0

2390.6

0.51

361

(1002224) Polysomnography panel

577

5680

1.01

0.07

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.07

0.07

2.8

3.4

—

(3012501) Base excess in Blood by calculation

185

1806

1.02

0.07

4.2

2.9

mmol/l

2.0

2.4

0.81

107

1122

(3013290) Carbon dioxide [Partial pressure] in Blood

185

1806

1.02

0.07

4.2

2.9

kpa

4.9

5.0

0.97

180

1771

(3000012) Reticulocyte production index

385

0.95

0.07

1.1

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

120

1218

0.98

0.07

1.4

1.3

umol/l

6.0

5.4

1.01

110

1125

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.85

0.06

1.1

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

166

1.08

0.06

2.9

1.7

nmol/l

323083.4

351100.7

0.03

137

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

121

0.90

0.06

1.0

u/ml

0.2

0.4

0.35

109

(4133840)

273

0.95

0.06

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

384

0.96

0.06

1.0

ng/l

242.7

333.8

2.61

284

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

147

1487

0.98

0.06

1.0

1.1

—

62.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

605

0.97

0.06

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

768

7579

1.01

0.06

3.6

3.2

mmol/l

1.2

1.47

672

6639

(3010726) Horse dander IgE Ab [Units/volume] in Serum

313

3144

0.99

0.06

1.1

u/ml

1.2

1.9

0.65

748

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

539

1.03

0.06

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

549

1.03

0.06

1.2

—

(3014271) Vancomycin [Susceptibility]

216

1.06

0.05

2.2

2.9

—

(3033799) Differential panel - Peritoneal fluid

201

0.94

0.05

2.1

1.9

—

(3009871) Measles virus Ab [Titer] in Serum

513

0.97

0.05

1.6

1.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

295

1.04

0.05

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

295

1.04

0.05

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

295

1.04

0.05

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

158

1.07

0.05

1.1

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.10

0.04

1.2

mmol/l

1.2

2.0

—

(3016750) Collection duration of Urine

384

1.04

0.04

2.5

2.2

min

499.7

506.3

0.22

317

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

571

0.97

0.04

1.1

1.2

108.6

110.6

0.19

513

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

690

1.02

0.04

3.3

2.6

u/ml

1030.7

833.9

0.23

685

(3019420) Tryptase [Mass/volume] in Serum or Plasma

851

0.98

0.04

1.8

1.4

ug/l

9.7

7.3

0.25

754

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

572

1.02

0.04

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

918

1.02

0.04

5.8

3.4

mmol/l

6.1

7.1

3.65

749

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

218

1.05

0.04

2.9

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

218

1.05

0.04

2.9

3.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

222

2227

0.99

0.04

1.0

u/ml

0.2

0.3

0.49

424

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

417

4170

0.99

0.04

1.5

1.4

nmol/l

0.5

0.14

336

3315

(3014599) Egg white IgE Ab [Units/volume] in Serum

116

1136

1.01

0.04

1.0

u/ml

0.9

2.0

0.69

252

(3042631) Mycobacterium sp identified in Specimen

820

1.02

0.03

2.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

227

2235

1.01

0.03

1.2

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

143

1438

0.99

0.03

1.7

1.6

—

(3022475) Manganese [Moles/volume] in Blood

108

0.92

0.03

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

108

0.92

0.03

1.3

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

759

0.98

0.03

1.5

1.4

umol/l

64.8

65.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

317

1.03

0.03

2.6

2.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

309

3091

0.99

0.03

1.1

u/ml

1.2

0.9

0.29

114

1234

(3027315) Oxygen [Partial pressure] in Blood

185

1822

1.01

0.03

4.3

2.9

kpa

9.1

9.0

0.41

180

1787

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

107

0.93

0.02

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

220

1.04

0.02

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

387

0.98

0.02

1.0

ng/l

787.1

775.1

0.05

277

(3013247) Albumin in CSF/Albumin in Serum or Plasma

387

0.98

0.02

1.0

1.1

mg/g

5.2

5.3

0.04

360

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.08

0.02

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

935

0.99

0.02

1.1

u/l

1.0

2.13

386

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

140

1379

1.01

0.02

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

149

1492

0.99

0.02

1.1

—

26.7

—

(40768795) Lymph node Pathology biopsy report

100

1004

0.99

0.02

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

328

3273

1.00

0.02

1.1

u/ml

5.1

4.7

0.19

153

1647

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

221

1.03

0.01

1.0

—

(3006270) Folate [Moles/volume] in Blood

855

1.01

0.01

1.1

nmol/l

402.9

403.6

0.01

793

(3002331) Protein [Mass/volume] in Peritoneal fluid

126

0.95

0.01

1.0

1.5

g/l

15.1

26.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

448

4464

1.00

0.01

1.3

ug/l

3.5

3.1

0.24

406

4076

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

588

1.01

0.01

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

252

2493

1.00

0.01

1.1

au/ml

9.7

10.8

0.11

178

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1479

14677

1.00

0.01

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

450

1.02

0.01

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

673

0.99

0.01

1.7

1.6

nmol/l

1.6

10.8

0.61

548

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

113

1.06

0.01

2.5

6.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

951

0.99

0.01

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

138

1378

0.99

0.00

3.4

3.3

u/ml

210.3

552.1

0.78

128

1247

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

107

1057

1.01

0.00

1.4

1.5

mmol/l

5.4

5.3

0.99

100

1009

(43055514) Macroprolactin [Presence] in Serum or Plasma

602

0.99

0.00

1.6

1.4

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

125

1.03

0.00

1.0

u/ml

1.9

0.1

—

(3024869) Neuronal Ab [Presence] in Serum

135

1.03

0.00

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

135

1.03

0.00

1.0

u/ml

0.1

0.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

288

1.00

0.00

1.1

1.0

ug/l

71.7

74.9

0.17

253

(44806071)

222

0.98

0.00

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

271

0.99

0.00

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

271

0.99

0.00

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

271

0.99

0.00

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

271

0.99

0.00

1.1

—

(3036603) Volume of Urine

651

0.99

0.00

1.4

1.6

1913.3

1989.2

—

120

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

199

1.00

0.00

3.0

1.9

e6/l

995.8

20269.7

1.00

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

124

1234

1.00

0.00

1.5

1.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

244

1.02

0.00

1.1

—

210.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

720

1.01

0.00

1.8

u/field

3.8

2.2

0.80

365

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

384

1.01

0.00

1.4

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

413

1.01

0.00

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

158

1573

1.00

0.00

2.8

2.5

ug/min

60.5

70.6

0.19

980

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

134

1.04

0.00

2.1

1.9

mmol/l

1.2

0.69

127

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.1

—

15.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

22.8

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(40758358) Immune stain study

0.88

0.00

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.88

0.00

1.0

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

299.4

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3000285) Sodium [Moles/volume] in Blood

1.01

0.00

1.0

1.1

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

145.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.97

0.00

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.89

0.00

1.2

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.99

0.00

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

0.97

0.00

3.7

1.9

ml/dl

14.8

14.7

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.92

0.00

4.2

4.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.93

0.00

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.96

0.00

1.0

1.3

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.96

0.00

1.0

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_FEMALE_GENITAL_DYSPLASIA_ALL and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_FEMALE_GENITAL_DYSPLASIA_ALL	1.196 [1.08, 1.33]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.073

During the follow-up period (1.1.1998 — 31.12.2019), 2759 out of 68239 females with N14_FEMALE_GENITAL_DYSPLASIA_ALL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_FEMALE_GENITAL_DYSPLASIA_ALL.

N-year risk	Females	Males
1	0.13%	No data
5	0.683%	No data
10	1.712%	No data
15	3.213%	No data
20	5.647%	No data

Relationships between endpoints

↥

Index endpoint: N14_FEMALE_GENITAL_DYSPLASIA_ALL – All dysplastic lesions of the cervix uteri, vagina or vulva

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

All dysplastic lesions of the cervix uteri, vagina or vulva

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints